Upload
nauticalwhirl
View
235
Download
42
Embed Size (px)
Citation preview
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Common Drug Endings
Drug Endings Drug Classification Drug Example
-zosin Alpha-adrenergic blocker used for HTN and BPH Prazosin-olol, -lol Beta-adrenergic blocker (BB) Metoprolol-zepam, -zolam Benzodiazepine (BZD) Diazepam,
alprazolam-pril Angiotensin-converting enzyme (ACE) inhibitor Lisinopril-artan Angiotensin-receptor blocker (ARB) Candesartan-dipine Calcium channel blocker (CCB) Amlodipine-statin Lipid-lowering drug Atorvastatin-ase, -plase Thrombolytic used to dissolve clots Alteplase-parin Anticoagulant Enoxaparin-sone Corticosteroid Prednisone-dronate Bisphosphonate for osteoporosis Alendronate-terol Bronchodilator used for asthma and COPD Albuterol
Continued
Common Drug Endings-cont’d
Drug Endings Drug Classification Drug Example
-tidine Histamine2 blocker-acid reducer Cimetidine-prazole Protein pump inhibitor-acid reducer Omeprazole-cillin Penicillin antibiotic Amoxicillincef-, ceph- Cephalosporin antibiotic Cefazolin-cycline Tetracycline antibiotic Tetracycline-floxacin Fluoroquinolone antibiotic Levofloxacin-thromycin Macrolide antibiotic Azithromycin-micin, mycin Aminoglycoside antibiotic Gentamicin-azole Antifungal Itraconazole-triptan Serotonin-receptor agonists used for migraines Sumatriptan-denafil, -dalafil PED5 inhibitors for erectile dysfunction Sildenafil-curium, Neuromuscular blockers used for muscle Pancuronium
-curonium relaxation during surgery
HTN, Hypertension; BPH, benign prostatic hypertrophy; COPD, chronic obstructive pulmonarydisease; PED5, Phosphodiesterase type 5.
DRUGS THAT SHOULD BE AVOIDED DURINGPREGNANCY BECAUSE OF
PROVEN OR STRONGLY SUSPECTEDTERATOGENICITY
The risks for most drugs used in pregnancy have not been determined.
(The benefits of treatment must balance the risks.)Category A: Remote risk of fetal harmCategory B: Slightly more risk than ACategory C: Greater risk than BCategory D: Proven risk of fetal harmCategory X: Proven risk of fetal harm
DRUGS THAT SHOULD BE AVOIDED DURINGPREGNANCY BECAUSE OF
PROVEN OR STRONGLY SUSPECTEDTERATOGENICITY
Anticancer/Immunosuppressants drugs (methotrexate)Antiseizure drugs (carbamazepine, valproic acid, phenytoin, and others)
Androgens (danazol, finasteride, dutasteride)ACE inhibitors (lisinopril and others)
Angiotensin-receptor blockers (losartan and others)Antithyroid drugs (propylthiouracil, methimazole)
Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin)HMG-CoA reductase inhibitors [ie, statins] (atorvastatin and others)
Isotretinoin (Accutane) used for acneLithium used for bipolar disorder
Nonsteroidal anti-inflammatory drugs (ibuprofen and others)Megadoses of vitamin A
Tetracycline antibiotics (minocycline, doxycycline)Warfarin (Coumadin)
Ch9
Drug
TherapyD
uringPregnancy
andBreast-Feeding
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Functions of Peripheral Adrenergic Receptor Subtypes
ReceptorSubtype Location Response to Receptor Activation
Alpha1 Eye Mydriasis: “Wide eyed with fear”Arterioles and veins (skin, viscera, Constriction: (BP increases), blood ismucous membranes) shunted away from the skin and viscera into
skeletal muscle; “cold with fear”Sex organs, male EjaculationBladder neck and prostatic capsule Contraction
Alpha2 Presynaptic nerve terminals Inhibition of transmitter release (NE):Decreased sympathetic nervous system (SNS) outflow to the blood vessels and heart reduces BP and pain
Beta1 Heart Increase in rate and force of contraction andin AV conduction velocity
Kidney Release of renin to raise BPBeta2 Arterioles (heart, lung, and skeletal Dilation increases blood flow to organs
muscle)Bronchi Dilation improves oxygenationUterus Relaxation prevents laborLiver Glycogenolysis increases blood glucoseSkeletal muscle Enhanced contraction, glycogenolysis
Dopamine Kidney Dilation of kidney vasculature
NE, Norepinephrine; AV, atrioventricular.
Functions of Peripheral Cholinergic Receptor Subtypes
ReceptorSubtype Location Response to Receptor Activation
Nicotinicn All autonomic nervous system Stimulation of parasympathetic and ganglia and the adrenal medulla sympathetic postganglionic nerves and
release of epinephrine from the adrenal medulla
Nicotinicm Neuromuscular junction Contraction of skeletal muscleMuscarinic All parasympathetic target organs:
Eye Miosis (pupils constrict)Heart Decreased rateLung Constriction of bronchi
Promotion of secretionsBladder Voiding of the urinary bladderGastrointestinal (GI) tract Salivation
Increases gastric secretions, intestinal tone,and motilityDefecation
Sweat glands Generalized sweatingSex organs ErectionBlood vessels Vasodilation (BP decreases)
MUSCARINIC AGONISTSPrototype: Bethanechol (Urecholine)
Other Muscarinic AgonistsCevimeline (Evoxac) for xerostomia (dry mouth) and inflammation of the cornea and conjunctiva
Pilocarpine for topical therapy of glaucomaMuscarine is found in poisonous mushrooms
MUSCARINIC AGONISTSPrototype: Bethanechol (Urecholine)
Mechanism of ActionActivates muscarinic receptors
Causes contraction of the detrusor muscle of the bladder and relaxation of the trigone and sphincter; the result is bladder emptying
UsesPostoperative and postpartum urinary retention
Adverse EffectsHypotension due to vasodilation and bradycardia
GI effects (excessive salivation, increased gastric acid, cramps, and diarrhea)Bladder rupture in patients with urinary obstructionExacerbation of asthma due to bronchoconstriction
Dysrhythmias in hyperthyroid patients due to reflex tachycardia
CH13
Physiologyofhe
PeripheralNervous
SystemCh
14M
uscarinicA
gonistsand
Antagonists
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
MUSCARINIC POISONINGMUSCARINIC POISONINGManifestation of Muscarinic Poisoning
Stimulation of muscarinic receptors causes profuse salivation,lacrimation (tearing), visual disturbances,
bronchospasm, diarrhea, bradycardia,hypotension, and cardiovascular collapse
Sources of Muscarinic PoisoningIngestion of Inocybe and Clitocybe mushrooms
Overdose with direct-acting muscarinic agonists (bethanechol, pilocarpine)Overdose with cholinesterase inhibitors (neostigmine [Prostigmin])
TreatmentAdministration of atropine (a muscarinic blocking agent)
Supportive care
MUSCARINIC ANTAGONISTS(ANTICHOLINERGIC DRUGS)
Prototype: Atropine
Other Muscarinic AntagonistsDrugs for an overactive bladder (eg, oxybutynin [Ditropan])
Scopolamine for motion sicknessIpratropium bromide (Atrovent) for COPD, rhinitis, and asthma
Antisecretory anticholinergics (glycopyrrolate [Robinul])Dicyclomine (Bentyl) for irritable bowel syndrome
Centrally acting anticholinergics for Parkinson’s disease:(trihexyphenidyl [Artane] and benztropine [Cogentin])
MUSCARINIC ANTAGONISTS(ANTICHOLINERGIC DRUGS)
Prototype: AtropineMechanism of ActionBlocks muscarinic receptors
Prevents receptor activation by endogenous acetylcholineIncreases heart rate (tachycardia)
Decreases salivary, bronchial, sweat, and acid-secreting cell secretionsRelaxes bronchial smooth muscles (bronchodilation)
Decreases bladder tone and GI motility (urinary retention)Dilates pupils (mydriasis)
Cycloplegia (relaxation of the ciliary muscle)Mild central nervous system (CNS) excitation, hallucinations, and delirium
UsesPreanesthesia to prevent bradycardia
Dilation of pupil for ocular examination or surgeryTreatment of bradycardia
Intestinal hypertonicity and hypermotility for dysenteryAntidote for muscarinic agonist poisoning
Adverse EffectsBlurry vision, photophobia, increased intraocular pressure
Urinary retention, dry mouth, constipationAnhidrosis and tachycardia (BUDCAT)
Ch14
Muscarinic
Agonists
andA
ntagonistsCh
14M
uscarinicA
gonistsand
Antagonists
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANTICHOLINERGIC SIDE EFFECTSBUDCAT
ANTICHOLINERGIC SIDE EFFECTSB- blurry vision, photophobia, and increased intraocular pressureU- urinary retentionD- dry mouth (xerostomia), decreased secretionsC- constipationA- anhidrosis (absence of sweat)T- tachycardia
Other Drugs with Anticholinergic Side EffectsFirst-generation antihistamines (diphenhydramine [Benadryl])
Antiemetics (prochlorperazine [Compazine], promethazine [Phenergan])First- and second-generation antipsychotic agents Tricyclic antidepressants (imipramine [Tofranil])
ANTICHOLINERGIC DRUGS FOR OVERACTIVEBLADDER (OAB)
Prototype: Oxybutynin (Ditropan, Ditropan XL, Oxytrol)
Other Anticholinergic Drugs for OABDarifenacin (Enablex)Solifenacin (Vesicare)
Tolterodine (Detrol, Detrol LA)Trospium (Sanctura, Sanctura XR)
ANTICHOLINERGIC DRUGS FOR OVERACTIVEBLADDER (OAB)
Prototype: Oxybutynin (Ditropan, Ditropan XL, Oxytrol)
Mechanism of ActionBlocks muscarinic (M3) receptors in the bladderInhibits bladder contractions and the urge to void
UsesOveractive bladder (urge incontinence)
Adverse EffectsBlurry vision, photophobia, increased intraocular pressure
Urinary retention, dry mouth, constipationAnhidrosis and tachycardia (BUDCAT)
CNS effects
Ch14
Muscarinic
Agonists
andA
ntagonistsCh
14M
uscarinicA
gonistsand
Antagonists
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CHOLINESTERASE INHIBITORSPrototype: Neostigmine (Prostigmin)
Other Reversible Cholinesterase InhibitorsAmbenonium (Mytelase)
Pyridostigmine (Mestinon)Edrophonium (Tensilon)
Physostigmine (Antilirium) for anticholinergic poisoningEchothiophate for treatment of glaucoma
Cholinesterase Inhibitors Used to Treat Alzheimer’s Disease
Donepezil (Aricept)Galantamine (Razadyne)Rivastigmine (Exelon)
Tacrine (Cognex)
CHOLINESTERASE INHIBITORSPrototype: Neostigmine (Prostigmin)
Mechanism of ActionPrevents degradation of acetylcholine (ACh)ACh accumulates at neuromuscular junction
Enhances effect of ACh to stimulate skeletal muscle contractionMuscarinic receptor activation
UsesMyasthenia gravis
Reversal of neuromuscular blockade in postoperative patientsGlaucoma, Alzheimer’s disease, and poisoning by muscarinic antagonists
Adverse EffectsExcessive glandular secretions, increased GI motilityUrinary urgency, bradycardia, sweating, and miosis
Toxic doses reduce force of muscle contractionCholinergic crisis—treat with atropine
NEUROMUSCULAR BLOCKERSPrototype: Succinylcholine (Anectine, Quelicin)
(Depolarizing neuromuscular blocker)
Nondepolarizing Neuromuscular BlockersAtracurium (Tracrium)
Cisatracurium (Nimbex)Pancuronium
Rocuronium (Zemuron)Vecuronium (Norcuron)
NEUROMUSCULAR BLOCKERSPrototype: Succinylcholine (Anectine, Quelicin)
(Depolarizing neuromuscular blocker)
Mechanism of ActionCauses paralysis of muscle by preventing repolarization (fasciculations)
UsesMuscle relaxation during endotracheal intubation
Short operative proceduresFacilitation of mechanical ventilationAdjunct to electroconvulsive therapy
Diagnosis of myasthenia gravis
Adverse EffectsProlonged paralysis in genetically determined individuals
Hypotension Malignant hyperthermia—treat with dantrolene
Hyperkalemia with cardiac arrestMuscle pain
Antibiotics can intensify effect
Ch15
CholinesteraseInhibitors
andTheir
Use
inM
yastheniaG
ravisCh
16D
rugsThat
BlockN
icotinicCholinergic
Transmission
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ADRENERGIC AGONISTSPrototype: Epinephrine
Other Adrenergic Agonists(Catecholamines and noncatecholamines)
Norepinephrine (Levophed)Isoproterenol (Isuprel)
DopamineDobutamine
PhenylephrineTerbutalineEphedrine
ADRENERGIC AGONISTSPrototype: Epinephrine
Mechanism of ActionActivates all four adrenergic receptors (alpha1, alpha2, beta1, and beta2)
Pupil dilation, arterial and venous vasoconstrictionIncreases heart rate and force of contraction
Bronchial dilation, glycogenolysis, enhanced muscle contraction
UsesCardiac arrest, heart failure, anaphylactic shock
AV heart block and asthmaDelays absorption of local anesthetic and controls superficial bleeding
Dilates pupil (mydriasis) for eye procedures
Adverse EffectsHypertensive crisis, dysrhythmias, angina pectoris
Necrosis after extravasationHyperglycemia in diabetic patients
ADRENERGIC AGONISTS Prototype: Phenylephrine
(Noncatecholamine)
Other Sympathomimetics Used for Nasal CongestionOxymetazoline (Afrin)
Pseudoephedrine (Sudafed)
ADRENERGIC AGONISTS Prototype: Phenylephrine
(Noncatecholamine)
Mechanism of ActionActivates alpha1 receptors
Constricts blood vessels of the skin, viscera, and mucous membranes
UsesTreatment of nasal congestionDelay of anesthetic absorption
Dilation of the pupil for ocular exam
Adverse EffectsHypertension
Necrosis
Ch17
Adrenergic
Agonists
Ch17
Adrenergic
Agonists
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ALPHA-ADRENERGIC ANTAGONISTS Prototype: Prazosin (Minipress)
Other Alpha BlockersTerazosin (Hytrin)
Doxazosin (Cardura)Tamsulosin (Flomax) for BPH onlyAlfuzosin (Uroxatral) for BPH only
Phentolamine for tissue necrosis
ALPHA-ADRENERGIC ANTAGONISTS Prototype: Prazosin (Minipress)
Mechanism of ActionBlocks alpha1 receptors
Dilates arteries and veinsRelaxes smooth muscle in the bladder neck and prostatic capsule
UsesEssential hypertension
Reversal of toxicity from alpha1 agonistsBenign prostatic hyperplasia
PheochromocytomaRaynaud’s disease
Adverse EffectsOrthostatic hypotension, reflex tachycardia
Nasal congestionInhibition of ejaculation
Use with sildenafil (Viagra) can lead to hypotensionSodium retention and increased blood volume
BETA-ADRENERGIC ANTAGONISTSFirst-Generation Nonselective Beta Blockers
Prototype: Propranolol (Inderal, InnoPran)
Other First-Generation Nonselective Beta BlockersNadolol (Corgard)
Sotalol (Betapace) for dysrhythmiasCarvedilol (Coreg) blocks beta1, beta2, and alpha1 receptors
Labetalol (Trandate) blocks beta1, beta2, and alpha1 receptors
BETA-ADRENERGIC ANTAGONISTSFirst-Generation Nonselective Beta Blockers
Prototype: Propranolol (Inderal, InnoPran)Mechanism of Action
Blocks beta1 and beta2 receptorsReduces heart rate, decreases force of ventricular contraction
Decreases conduction through AV node, decreases cardiac outputSuppresses secretion of renin
Bronchoconstriction through beta2 blockade in the lungReduces glycogenolysis through beta2 blockade in muscle and liver
UsesHypertension, angina pectoris, cardiac dysrhythmias
Myocardial infarction, hyperthyroidismMigraine headache prophylaxis, “stage fright”
Adverse EffectsBradycardia, AV heart block, heart failure
Rebound cardiac excitation (tachycardia) after abrupt withdrawal Bronchoconstriction in asthmatics
Inhibition of glycogenolysis, CNS effects mask tachycardia associated with hypoglycemia indicated in diabetics
Avoid in patients with asthma, diabetes, depression, or severe allergies
Ch18
Adrenergic
Antagonists
Ch18
Adrenergic
Antagonists
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
BETA-ADRENERGIC ANTAGONISTSSecond-Generation Cardioselective Beta Blockers
Prototype: Metoprolol (Lopressor, Toprol XL)
Other Cardioselective Beta BlockersAcebutolol (Sectral)Atenolol (Tenormin)Betaxolol (Kerlone)Bisoprolol (Zebeta)
Esmolol (Brevibloc) for dysrhythmias
BETA-ADRENERGIC ANTAGONISTSSecond-Generation Cardioselective Beta Blockers
Prototype: Metoprolol (Lopressor, Toprol XL)Mechanism of Action
Blocks cardiac beta1 receptorsReduces heart rate, decreases force of ventricular contraction
Decreases conduction through AV node, decreases cardiac outputSuppresses renin
Minimal blockade of beta2 receptors (less bronchoconstriction)Not likely to inhibit glycogenolysis
Preferred for patients with asthma or diabetes
UsesHypertension, angina pectoris, heart failure
Myocardial infarction
Adverse EffectsBradycardia, reduction of cardiac output, AV heart block
Rebound cardiac excitation (tachycardia) after abrupt withdrawalMasks tachycardia associated with hypoglycemia in diabetics
BETA-ADRENERGIC ANTAGONISTSThird-Generation Vasodilating
Alpha and Beta Blockers
Prototype: Labetalol (Normodyne, Trandate)
Other Alpha and Beta BlockersCarvedilol (Coreg) for heart failure
(blocks beta1, beta2, and alpha1 receptors)Nebivolol (Bystolic) blocks beta receptors
(promotes release of nitric acid, a vasodilator)
BETA-ADRENERGIC ANTAGONISTSThird-Generation Vasodilating
Alpha and Beta Blockers
Prototype: Labetalol (Normodyne, Trandate)Mechanism of Action
Blocks alpha1 receptors on veins, causing vasodilationBlocks beta1 receptors in the heart and beta2 receptors in the lung
UsesHypertension, hypertensive crisis
Adverse EffectsDizziness, orthostatic hypotension, ventricular dysrhythmias
Nasal congestion, sexual dysfunction,bronchospasm
Ch18
Adrenergic
Antagonists
Ch18
Adrenergic
Antagonists
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CENTRALLY ACTING ALPHA2 AGONISTSPrototype: Clonidine (Catapres)
Other Alpha2 AgonistsGuanabenz (Wytensin)
Guanfacine (Tenex)Methyldopa*
*Adverse effects of methyldopa are hemolytic anemia and hepatotoxicity A positive Coombs’ test can occur with methyldopa
CENTRALLY ACTING ALPHA2 AGONISTSPrototype: Clonidine (Catapres)
Mechanism of ActionActivates alpha2 receptors in the CNS
Reduces sympathetic outflow to the heart and blood vessels Reduces stimulation of adrenergic receptors in the periphery
Net effect of cardiac suppression and vasodilation is decreased blood pressure
UsesHypertension
Epidural infusion to relieve severe cancer pain
Adverse EffectsDrowsiness and sedationXerostomia (dry mouth)
HypotensionBradycardia, decrease in cardiac output
Rebound hypertension in response to abrupt withdrawalFetal harm
DOPAMINERGICS FOR PARKINSON’S DISEASEPrototype: Levodopa/Carbidopa (Sinemet)
Other Drugs That Increase DopaminePramipexole (Mirapex)
Ropinirole (Requip)Entacapone (Comtan)Selegiline (Eldepryl)
Amantadine (Symmetrel)
DOPAMINERGICS FOR PARKINSON’S DISEASEPrototype: Levodopa/Carbidopa (Sinemet)
Mechanism of ActionLevodopa increases synthesis of dopamine in the striatum
Carbidopa enhances effect of levodopa
UsesReduces symptoms of Parkinson’s disease
Adverse EffectsEffects take several months to develop
Loss of effect occurs over timeNausea, vomiting, dyskinesias
Postural hypotension, psychosisDark sweat and urine, may activate melanoma
Ch19
Indirect-Acting
Antiadrenergic
Agents
Ch21
Drugs
forParkinson’s
Disease
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CHOLINESTRASE INHIBITORS FOR ALZHEIMER’S DISEASE
Prototype: Donepezil (Aricept)
Other Cholinesterase InhibitorsTacrine (Cognex) rarely used due to hepatotoxicity
Rivastigmine (Exelon)Galantamine (Razadyne)
Other Drugs for Alzheimer’s DiseaseMemantine (Namenda)
N-methyl-D-aspartate (NMDA)–receptor antagonists for moderate to severe disease
CHOLINESTRASE INHIBITORS FOR ALZHEIMER’S DISEASE
Prototype: Donepezil (Aricept)Mechanism of Action
Prevents the breakdown of acetylcholine (ACh)Increases ACh at cholinergic synapses
May slow progression of Alzheimer’s diseaseMinimal improvement of memory and cognitive function
UsesAlzheimer’s disease
Adverse EffectsCholinergic effects
Nausea, vomiting, dyspepsia, diarrheaBradycardia
Bronchoconstriction
ANTIEPILEPTIC DRUGS (AEDs)Prototype: Phenytoin (Dilantin)
Other AEDsCarbamazepine (Tegretol)
Valproic acid (Depakene, Depakote, Depacon)Ethosuximide (Zarontin)
PhenobarbitalFosphenytoin (Cerebyx), a prodrug form of phenytoin
ANTIEPILEPTIC DRUGS (AEDs)Prototype: Phenytoin (Dilantin)
Mechanism of ActionInhibits entry of sodium into neurons
Suppresses action potential of neurons
UsesEpilepsy
Cardiac dysrhythmias
Adverse EffectsNystagmus, sedation, ataxia, diplopia, cognitive impairment
Gingival hyperplasia, rash, hirsutism, liver damageFetal harm, bleeding tendencies in newbornsNarrow therapeutic range (10 to 20 mcg/mL)Inject slowly (do not exceed 50 mg/minute)
Dysrhythmias and hypotension if injected too fastUse normal saline to prevent precipitation
Induces the metabolism of other drugs such as:oral contraceptives, warfarin, and glucocorticoids (drug effect is decreased)
Withdraw over 6 to 8 weeks to prevent seizures
All AEDs may increase suicidal thoughts and behaviors
Ch22
Alzheim
er’sD
iseaseCh
24D
rugsfor
Epilepsy
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANTIEPILEPTIC DRUGS (AEDs)Prototype: Valproic Acid (Depakote)
Newer Antiepileptic DrugsOxcarbazepine (Trileptal)Lamotrigine (Lamictal)Gabapentin (Neurontin)
Pregabalin (Lyrica)Levetiracetam (Keppra)Topiramate (Topamax)
Tiagabine (Gabitril)Zonisamide (Zonegran)
Felbamate (Felbatol)Vigabatrin (Sabril)
ANTIEPILEPTIC DRUGS (AEDs)Prototype: Valproic Acid (Depakote)
Mechanism of ActionBlocks sodium channels to suppress neurons
Suppresses calcium influxIncreases inhibitory influence of gamma-aminobutyric acid (GABA)
UsesEpilepsy, bipolar disorder, migraine headaches
Adverse EffectsNausea, vomiting, indigestion
Hepatotoxicity, pancreatitis, fetal harmWeight gain, rash, hair loss, tremor
Blood dyscrasias
MUSCLE RELAXANTSPrototype: Metaxalone (Skelaxin)
Other Centrally Acting Muscle RelaxantsBaclofen (Lioresal)Diazepam (Valium)
DantroleneCarisoprodol (Soma)
Cyclobenzaprine (Flexeril, Fexmid)Cyclobenzaprine ER (Amrix)
Chlorzoxazone (Paraflex, Parafon Forte, Remular-S)Methocarbamol (Robaxin)
Orphenadrine (Norflex)Tizanidine (Zanaflex)
MUSCLE RELAXANTSPrototype: Metaxalone (Skelaxin)
Mechanism of ActionUnclear; sedative properties may cause relaxation
UsesRelief of spasm resulting from muscle injury
Adverse EffectsCNS depressionHepatotoxicity
Physical dependence
Ch24
Drugs
forEpilepsy
Ch25
Drugs
forM
uscleSpasm
andSpasticity
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
LOCAL ANESTHETICSPrototype: Lidocaine
Other Local AnestheticsProcaine (Novocain)
Bupivacaine (Marcaine)
LOCAL ANESTHETICSPrototype: Lidocaine
Mechanism of ActionStops axonal conduction by blocking sodium channels in axonal membrane
Stops nerve conduction
UsesSurgical anesthesia
Adverse EffectsCentral nervous system excitation followed by depression
Convulsions, respiratory depressionBradycardia, heart block, reduced contractile force
Cardiac arrest, hypotension, allergic reactions
GENERAL ANESTHETICSInhaled Anesthetics
Halothane (Fluothane)Isoflurane (Forane)Enflurane (Ethrane)
Desflurane (Suprane)Sevoflurane (Ultane)
Nitrous oxide
Intravenous AnestheticsThiopental sodium (Pentothal)Methohexital sodium (Brevital)
Diazepam (Valium)Midazolam (Versed)Propofol (Diprivan)
Etomidate (Amidate)Ketamine (Ketalar)
Droperidol plus fentanyl (Innovar)
GENERAL ANESTHESTICS
Mechanism of ActionEnhance transmission at inhibitory synapses (GABA)Depress transmission at excitatory synapses (NMDA)
UsesSurgery
Adverse EffectsRespiratory and cardiac depression
Sensitization of the heart to catecholamines, leading to dysrhythmiasMalignant hyperthermia—treat with dantrolene
Aspiration of gastric contentsToxicity to operating room personnel
Hepatotoxicity
Ch26
LocalAnesthetics
Ch27
GeneralA
nesthetics
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
OPIOID ANALGESICSPrototype: Morphine
Other Strong Opioid AgonistsFentanyl (Sublimaze, Duragesic, Fentora, Actiq, Ionsys)
Alfentanil (Alfenta) sufentanil (Sufenta)Remifentanil (Ultiva)Meperidine (Demerol)
Methadone (Diskets, Dolophine, Methadose)Heroin
Hydromorphone (Dilaudid)Oxymorphone (Opana)
Levorphanol (Levo-Dromoran)
Moderate to Strong Opioid AgonistsCodeine
Oxycodone (OxyContin, Percodan, Percocet)Hydrocodone (Vicodin, Lortab)
Propoxyphene (Darvon)
OPIOID ANALGESICSPrototype: Morphine
Mechanism of ActionActivates mu receptors
Produces analgesia, euphoria, sedation
UsesRelief of pain
Adverse EffectsRespiratory depression, constipation
Orthostatic hypotension, urinary retention, cough suppressionBiliary colic, emesis, elevation of intracranial pressureEuphoria, dysphoria, sedation, miosis, neurotoxicity
Tolerance and physical dependenceProlonged use affects hormone and immune functions
Reversed with naloxone (Narcan)
AGONIST-ANTAGONIST OPIOIDSPrototype: Pentazocine (Talwin)
Other Partial AgonistsNalbuphine (Nubain)Butorphanol (Stadol)
Buprenorphine (Buprenex, Subutex, Suboxone)
AGONIST-ANTAGONIST OPIOIDSPrototype: Pentazocine (Talwin)
Mechanism of ActionActs as an agonist at kappa receptors and antagonist at mu receptors
Produces analgesia and sedationMild respiratory depression, increased cardiac work
UsesRelief of mild to moderate pain
Adverse EffectsPhysical dependence
Unpleasant reactions (anxiety, strange thoughts, nightmares, hallucinations)If administered to a patient physically dependent on a pure opioid agonist,
withdrawal syndrome can occur
Ch28
Opioid
(Narcotic)A
nalgesicsand
Antagonists
Ch28
Opioid
(Narcotic)A
nalgesicsand
Antagonists
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
OPIOID ANTAGONISTSPrototype: Naloxone (Narcan)
Other Opioid AntagonistsMethylnaltrexone (Relistor)
Nalmefene (Revex)Naltrexone (ReVia, Vivitrol)
OPIOID ANTAGONISTSPrototype: Naloxone (Narcan)
Mechanism of ActionReverses the effects of opioids
UsesReversal of opioid overdose
Reversal of postoperative opioid effectReversal of neonatal respiratory depression
Adverse EffectsMinimal
NONOPIOID CENTRALLY ACTING ANALGESICSPrototype: Tramadol (Ultram, Ultram ER)
Other Nonopioid AnalgesicsClonidine (Duraclon)
Ziconotide (Prialt) Dexmedetomidine (Precedex)
NONOPIOID CENTRALLY ACTING ANALGESICSPrototype: Tramadol (Ultram, Ultram ER)
Mechanism of ActionAnalog of codeine, weakly activates mu opioid receptors
Blocks uptake of norepinephrine and serotonin Activates monoaminergic spinal inhibition of pain
UsesRelieves moderate to severe pain
Adverse EffectsMild sedation, dizziness, headache, dry mouth, constipation
Increases the risk of seizureMinimal respiratory depression
CNS depression if used with ETOHHTN if used with monoamine oxidase (MAO) inhibitors
Serotonin syndrome if used with antidepressants or triptansLow potential for abuse; not a scheduled drug
Ch28
Opioid
(Narcotic)A
nalgesicsand
Antagonists
Ch28
Opioid
(Narcotic)A
nalgesicsand
Antagonists
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ERGOT ALKALOIDSPrototype: Ergotamine (Ergomar)
Other Ergot AlkaloidsDihydroergotamine (D.H.E. 45, Migranal)Ergotamine 1 caffeine (Cafergot, Ercaf)
ERGOT ALKALOIDSPrototype: Ergotamine (Ergomar)
Mechanism of ActionAlters transmission at serotonergic, dopaminergic,
and alpha-adrenergic junctionsActivates serotonin receptors
Suppresses inflammation by blocking calcitonin gene–related peptide(CGRP)
Promotes constriction
Uses Migraine and cluster headaches
Adverse EffectsNausea and vomiting
Weakness in the legs, myalgias, tingling in the fingers and toesAngina-like pain
Tachycardia or bradycardiaOverdose can cause ergotism (ischemia due to constriction of vessels)
Fetal harm
SEROTONIN1B/1D–RECEPTOR AGONISTS (TRIPTANS)Prototype: Sumatriptan (Imitrex)
Other TriptansNaratriptan (Amerge)Rizatriptan (Maxalt)Zolmitriptan (Zomig)Almotriptan (Axert)Frovatriptan (Frova)Eletriptan (Replax)
Sumatriptan 1 naproxen (Treximet)
SEROTONIN1B/1D–RECEPTOR AGONISTS (TRIPTANS)Prototype: Sumatriptan (Imitrex)
Mechanism of ActionBinds to 5-HT1B/1D (serotonin) receptors to cause vasoconstriction
Reduces release of inflammatory peptides (CGRT)Diminishes perivascular inflammation
Relieves migraine pain and associated symptoms
UsesMigraine headache
Adverse EffectsChest symptoms (heavy arms and chest pressure)
Coronary vasospasmTeratogenesis
Vertigo, malaise, fatigue, tingling sensation
Ch30
Drugs
forH
eadacheCh
30D
rugsfor
Headache
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
FIRST-GENERATION (CONVENTIONAL)ANTIPSYCHOTICS
Prototype: Chlorpromazine (Thorazine)
Other First-Generation Conventional NeurolepticsLow Potency
Chlorpromazine (Thorazine)Thioridazine (Mellaril)
Medium PotencyLoxapine (Loxitane)Molindone (Modan)
Pherphenazine
High PotencyHaloperidol (Haldol), Haldol Decanoate (depot preparation)
Fluphenazine (Prolixin Decanoate [depot preparation])Trifluoperazine, Thiothixene (Navane)
Pimozide (Orap)
FIRST-GENERATION (CONVENTIONAL)ANTIPSYCHOTICS
Prototype: Chlorpromazine (Thorazine)Mechanism of Action
Relieves positive symptoms of schizophreniaBlocks receptors for dopamine (D2), acetylcholine (ACh),
histamine, and norepinephrine (NE)
UsesSchizophrenia, bipolar disorder, Tourette’s syndrome
Prevention of emesis, and dementia
Adverse EffectsExtrapyramidal symptoms (EPS)
(acute dystonia, parkinsonism, akathisia, tardive dyskinesia)Neuroleptic malignant syndrome
(lead pipe rigidity, high fever, autonomic instability)Anticholinergic effects (BUDCAT), orthostatic hypotension
Sedation, neuroendocrine effects, seizuresSexual dysfunction, increased risk of sunburn
Agranulocytosis, dysrhythmias (prolongs QT interval)Counteracts the effect of levodopa used in Parkinson’s disease
Rate of mortality doubles when used in elderly patients with dementiaIncreases prolactin levels
SECOND-GENERATION (ATYPICAL) ANTIPSYCHOTICSPrototype: Clozapine (Clozaril)
Other Second-Generation (Atypical) AntipsychoticsRisperidone (Risperdal)
Risperdal Consta (depot preparation)Paliperidone (Invega)Olanzapine (Zyprexa)Quetiapine (Seroquel)Ziprasidone (Geodon)Aripiprazole (Abilify)
SECOND-GENERATION (ATYPICAL) ANTIPSYCHOTICSPrototype: Clozapine (Clozaril)
Mechanism of ActionRelieves positive, negative, and cognitive signs and symptoms of
schizophreniaBlocks receptors for serotonin (5-HT), D2, ACh, histamine, and NE
UsesSchizophrenia
Levodopa-induced psychosisBipolar disorder
Adverse EffectsAgranulocytosis
Metabolic effects (weight gain, diabetes, dyslipidemia)Seizures, myocarditis, orthostatic hypotension
Rate of mortality doubles when used in elderly patients with dementiaSedation, weight gain, anticholinergic effects (BUDCAT)
Lower risk of extrapyramidal effectsCosts 10 times more than conventional agents
Ch31
Antipsychotic
Agents
andTheir
Use
inSchizophrenia
Ch31
Antipsychotic
Agents
andTheir
Use
inSchizophrenia
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
TRICYCLIC ANTIDEPRESSANTS (TCAs)Prototype: Imipramine (Tofranil)
Other TCAsAmitriptyline
Clomipramine (Anafranil)Desipramine (Norpramin)
Doxepin (Sinequan)Maprotiline
Nortriptyline (Aventyl, Pamelor)Protriptyline (Vivactil)
Trimipramine (Surmontil)
TRICYCLIC ANTIDEPRESSANTS (TCAs)Prototype: Imipramine (Tofranil)
Mechanism of ActionInhibits reuptake of norepinephrine (NE) and serotonin
(more serotonin and NE are available at the synapse)
UsesDepression, bipolar disorder, neuropathic pain
Chronic insomniaAttention deficit/hyperactivity disorder
Panic disorder, obsessive-compulsive disorder (OCD)
Adverse EffectsOrthostatic hypotension, anticholinergic effects (BUDCAT)
Diaphoresis (sweating), sedationCardiotoxicity, seizures, hypomania
Increased risk of suicide, especially in younger individualsMany drug interactions
Selective serotonin reuptake inhibitors (SSRIs) preferred for treatment ofdepression
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)Prototype: Fluoxetine (Prozac, Sarafem)
Other SSRIsParoxetine (Paxil, Paxil CR, Pexeva)
Fluvoxamine (Luvox)Sertraline (Zoloft)
Citalopram (Celexa)Escitalopram (Lexapro)
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)Prototype: Fluoxetine (Prozac, Sarafem)
Mechanism of ActionInhibits serotonin reuptake (more serotonin is available at the synapse)
UsesMajor depression, bipolar disorder
Obsessive-compulsive disorderPanic disorder, bulimia nervosaPremenstrual dysphoric disorder
Adverse EffectsSexual dysfunction, nausea, headache, insomnia
Weight gain, serotonin syndromeWithdrawal syndrome
Neonatal abstinence syndrome and persistent pulmonary hypertensionTeratogenesis
Increased risk of suicideExtrapyramidal side effects
Bruxism (clenching and grinding of the teeth)Decrease in platelet aggregation, leading to bleeding
Hyponatremia
Ch32
Antidepressants
Ch32
Antidepressants
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
SEROTONIN/NOREPINEPHRINE REUPTAKEINHIBITORS (SNRIs)
Prototype: Venlafaxine (Effexor)
Other SNRIsDuloxetine (Cymbalta)
(indicated for physical pain and diabetic neuropathy; can cause liver toxicity)Desvenlafaxine (Pristiq)
SEROTONIN/NOREPINEPHRINE REUPTAKEINHIBITORS (SNRIs)
Prototype: Venlafaxine (Effexor)Mechanism of Action
Blocks norepinephrine (NE) and 5-HT uptake; weak blockade of dopamine uptake
(more transmitter available at synapse)
UsesMajor depression, generalized anxiety disorder
Social anxiety disorder (social phobia)
Adverse EffectsNausea, headache, anorexia, nervousness, sweating, somnolence, and insomnia
Weight loss, diastolic hypertensionSexual dysfunction, hyponatremia
Increased risk of suicideIntense withdrawal syndrome with abrupt discontinuation
(anxiety, agitation, tremors, headache, vertigo, nausea, tachycardia, tinnitus)Neonatal withdrawal syndrome
Serotonin syndromeFetal harm
MONOAMINE OXIDASE INHIBITORS (MAOIs)Prototype: Isocarboxazid (Marplan)
Other MAOIsPhenelzine (Nardil)
Tranylcypromine (Parnate)Transdermal selegiline (Emsam)
MONOAMINE OXIDASE INHIBITORS (MAOIs)Prototype: Isocarboxazid (Marplan)
Mechanism of ActionIncreases NE and serotonin by blocking the enzyme that inactivates them
UsesAtypical depression, bulimia nervosa, OCD, and panic attacks
Adverse EffectsCNS stimulation (anxiety, insomnia, agitation, hypomania, and mania)
Orthostatic hypotension due to vasodilationHypertensive crisis from high levels of dietary tyramine
Many drug interactionsSSRIs preferred for treatment of depression
Ch32
Antidepressants
Ch32
Antidepressants
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ATYPICAL ANTIDEPRESSANTSPrototype: Bupropion (Wellbutrin, Zyban)
Other Atypical AntidepressantsNefazodone (can cause liver failure)
Mirtazapine (Remeron)AmoxapineReboxetine
Trazodone (Desyrel) has sedative effects
ATYPICAL ANTIDEPRESSANTSPrototype: Bupropion (Wellbutrin, Zyban)
Mechanism of ActionUnclear; may be related to blockade of dopamine uptake
UsesMajor depressive disorder
Prevention of seasonal affective disorder (SAD)Smoking cessation
Relief of neuropathic pain (unlabeled use)Attention deficit/hyperactivity disorder (unlabeled use)
Adverse EffectsRisk of seizure
May increase the risk of suicideAgitation, headache, dry mouth, constipation, weight loss,
GI upset, dizziness, tremor, insomnia, blurred vision, and tachycardia
MOOD-STABILIZING DRUGSPrototype: Lithium (Lithobid, Lithonate, Lithotabs)
Other Mood-Stabilizing DrugsAntiepileptic Drugs
Valproic acidCarbamazepine
Lamotrigine (Lamictal)
Atypical AntipsychoticsOlanzapine (Zyprexa)Aripiprazole (Abilify)Ziprasidone (Geodon)
MOOD-STABILIZING DRUGSPrototype: Lithium (Lithobid, Lithonate, Lithotabs)
Mechanism of ActionMechanism unclear; may alter ions and neurotransmitters
May protect against neuronal atrophy and/or promote neuronal growth
UsesStabilizes mood in patients with bipolar disorder
Reduces euphoria, hyperactivity, and other symptomsPreferred for patients with classic (euphoric) mania
Adverse EffectsAccumulates to toxic levels in the presence of a low sodium level
Lithium levels must be kept below 1.5 mEq/LBlood levels are drawn 12 hours after evening dose
Signs of toxicity include fine hand tremor, GI upset, thirst, polyuria, andmuscle weakness
Chronic use can lead to renal toxicity and hypothyroidismFDA Pregnancy Risk Category D
Reversible leukocytosis, dermatologic reactionsDrug interactions occur with diuretics, NSAIDs, and anticholinergics
Ch32
Antidepressants
Ch33
Drugs
forBipolar
Disorder
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
MOOD-STABILIZING ANTIEPILEPTIC DRUGSPrototype: Valproic Acid (Depakote)
Other AEDs used for BPDCarbamazepine (Equetro, Tegretol)—monitor CBC
Lamotrigine (Lamictal)
MOOD-STABILIZING ANTIEPILEPTIC DRUGSPrototype: Valproic Acid (Depakote)
Mechanism of ActionSuppresses mania and stabilizes mood
UsesMood stabilizer for patients with bipolar disorder
Adverse EffectsGI disturbances, weight gain
Thrombocytopenia, pancreatitis, liver failureTarget trough level is 50 to 120 mg/mL
Fetal harm
BENZODIAZEPINES (BZDs)Prototype: Alprazolam (Xanax)
Chlordiazepoxide (Librium)Clonazepam (Klonopin)Clorazepate (Tranxene)
Diazepam (Valium)Estazolam (ProSom)
Flurazepam (Dalmane)Lorazepam (Ativan)Midazolam (Versed)Oxazepam (Serax)Quazepam (Doral)
Temazepam (Restoril)Triazolam (Halcion)
BENZODIAZEPINES (BZDs)Prototype: Alprazolam (Xanax)
Mechanism of ActionDepresses central nervous system function
Reduces anxiety, promotes sleepPotentiates the actions of GABA (an inhibitory neurotransmitter)
UsesAnxiety, insomnia, seizure disorder, induction of anesthesiaMuscle spasm, panic disorder, and withdrawal from alcohol
Adverse EffectsCNS depression, anterograde amnesia
Sleep driving and other complex sleep-related behaviorsParadoxic effects
Weak respiratory depression if given orallyIV administration can cause severe respiratory depression
Abuse and addiction, teratogenicDo not mix with other CNS depressants or alcohol
Reversal agent is flumazenil (Romazicon)
Ch33
Drugs
forBipolar
Disorder
Ch34
Sedative-Hypnotic
Drugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
BENZODIAZEPINE-LIKE DRUGSPrototype: Zolpidem (Ambien)
Other BZD-like drugsZaleplon (Sonata)
Eszopiclone (Lunesta)
Melatonin AgonistRamelteon (Rozerem)
BENZODIAZEPINE-LIKE DRUGSPrototype: Zolpidem (Ambien)
Mechanism of ActionPotentiate the actions of GABA (an inhibitory neurotransmitter)
UsesShort-term management of insomnia
Adverse EffectsDaytime drowsiness, dizziness
Sleep driving and other complex sleep-related behaviorsDo not use with alcohol or other CNS depressants
BARBITURATESCNS Depressants
ThiopentalSecobarbital
Phenobarbital
Miscellaneous Sedative-HypnoticsChloral hydrate (Aquachloral Supprettes, Somnote)
Meprobamate (Miltown)Paraldehyde (Paral)
Trazodone (Desyrel) antidepressantDiphenhydramine (Sominex)
Doxylamine (Unisom)
BARBITURATESCNS Depressants
Mechanism of ActionPotentiate the actions of GABA (an inhibitory neurotransmitter)
UsesInsomnia
Suppression of seizures, induction of general anesthesiaTreatment of manic states
Adverse EffectsRespiratory depression, decreased blood pressure and heart rate
Induction of hepatic drug-metabolizing enzymes (increases the metabolismof other drugs rendering them less effective)
May lead to tolerance and dependenceFrequently used as vehicles for suicide
Teratogenic
Ch34
Sedative-Hypnotic
Drugs
Ch34
Sedative-Hypnotic
Drugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CNS STIMULANTS Prototype: Methylphenidate
(Ritalin, Metadate, Concerta, Daytrana)
Other CNS StimulantsDexmethylphenidate (Focalin)
DexedrineAdderall
Modafinil (Provigil)Atomoxetine (Strattera)—nonstimulant
CNS STIMULANTSPrototype: Methylphenidate
(Ritalin, Metadate, Concerta, Daytrana)Mechanism of Action
Promotes norepinephrine (NE) and dopamine (DA) releaseInhibits NE and DA reuptake
UsesAttention deficit/hyperactivity disorder (ADHD)
Narcolepsy
Adverse EffectsInsomnia, reduced appetite, weight loss
Palpitations, hypertension, angina, dysrhythmias, psychosisAbrupt discontinuation can lead to withdrawal reactions
Potential for abuse (Schedule II)Sudden death
DISULFIRAM (ANTABUSE)Aversion Therapy for Alcoholism
DISULFIRAM (ANTABUSE)Aversion Therapy for Alcoholism
Mechanism of ActionDisrupts alcohol metabolism by blocking enzyme
Acetaldehyde accumulates and produces unpleasant effects
UsesAlcohol abuse
Adverse EffectsNausea, vomiting, flushing, palpitations, headacheSweating, blurry vision, hypotension, chest pain Shock occurs with ingestion of 7 mL of alcohol
Ch36
CNS
Stimulants
andA
ttention-Deficit/H
yperactivityD
isorderCh
38D
rugA
buseII:A
lcohol
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
HIGH-CEILING (LOOP) DIURETICSPrototype: Furosemide (Lasix)
Other High-Ceiling DiureticsEthacrynic acid (Edecrin)
Bumetanide (Bumex)Torsemide (Demadex)
HIGH-CEILING (LOOP) DIURETICSPrototype: Furosemide (Lasix)
Mechanism of ActionBlocks reabsorption of sodium and chloride in the descending limb of
Henle’s loop to promote urinationProduces profound diuresis
UsesRapid mobilization of fluid
Pulmonary edema resulting from heart failure or renal or liver diseaseEspecially useful in patients with renal insufficiency
Adverse EffectsHyponatremia, hypochloremia, dehydration, hypotension, hypokalemia
Ototoxicity, hyperglycemia, hyperuricemia, fetal harmRaises LDL and lowers HDL (minimally)
May cause dysrhythmias when used with digoxin (reduces potassium)
THIAZIDE DIURETICSPrototype: Hydrochlorothiazide (HCTZ)
Other Thiazides and Related DiureticsChlorothiazide (Diuril)
Methyclothiazide (Enduron)Chlorthalidone (Hygroton, Thalitone)
Metolazone (Zaroxolyn)
THIAZIDE DIURETICSPrototype: Hydrochlorothiazide (HCTZ)
Mechanism of ActionBlocks reabsorption of sodium and chloride in the early segment of the distal
convoluting tubule to promote urination
UsesTreatment of hypertension
Mobilization of edema with mild heart failure, hepatic or renal diseaseIneffective when GFR is low (,15 to 20 mL/min)
Adverse EffectsHyponatremia, hypochloremia, dehydration
Hypokalemia, magnesium deficiency, and hypotensionHyperglycemia, hyperuricemia, increase in LDL and triglycerides
May cause dysrhythmias when used with digoxin (reduces potassium)Fetal harm
Ch40
Diuretics
Ch40
Diuretics
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
POTASSIUM-SPARING DIURETICSPrototype: Spironolactone (Aldactone)
Other Potassium-Sparing DiureticsTriamterene (Dyrenium)
Amiloride (Midamor)
Other Aldosterone Blockers Eplerenone (Inspra)
Not considered a diureticUsed for heart failure
POTASSIUM-SPARING DIURETICSPrototype: Spironolactone (Aldactone)
Mechanism of ActionBlocks the actions of aldosterone in the distal nephron
Produces minimal diuresisCauses retention of potassium and increased excretion of sodium
UsesHypertension and edema
Used in combination with other diuretics to counterbalance potassium lossHeart failure
(Blocks the negative effects of aldosterone on the heart and blood vessels)Primary hyperaldosteronism, premenstrual syndrome
Polycystic ovary syndrome, and acne
Adverse EffectsHyperkalemia, dysrhythmias
Endocrine effects (Gynecomastia, menstrual irregularities, impotence, and hirsutism)
OSMOTIC DIURETICSPrototype: Mannitol (Osmitrol)
OSMOTIC DIURETICSPrototype: Mannitol (Osmitrol)
Mechanism of ActionCreates an osmotic force in the lumen of the nephron
Promotes diuresis by inhibiting passive reabsorption of water
UsesProphylaxis of renal failure
Reduction of intracranial pressureReduction of intraocular pressure
Adverse EffectsEdema
CHF and pulmonary edema
Ch40
Diuretics
Ch40
Diuretics
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANGIOTENSIN-CONVERTING ENZYME (ACE)INHIBITORS
Prototype: Ramipril (Altace)
Other ACE InhibitorsBenazepril (Lotensin)Captopril (Capoten)Enalapril (Vasotec)
Fosinopril (Monopril)Lisinopril (Prinivil and Zestril)
Moexipril (Univasc)Perindopril (Aceon)Quinapril (Accupril)Trandolapril (Mavik)
ANGIOTENSIN-CONVERTING ENZYME (ACE)INHIBITORS
Prototype: Ramipril (Altace)Mechanism of Action
Inhibits ACE, reducing levels of angiotensin IIDilates arterioles and veins to reduce blood volume and BP
Prevents pathologic changes in cardiac structure
UsesHypertension, heart failure, MI
Diabetic and nondiabetic nephropathyPrevention of MI, stroke, and death
Adverse EffectsHypotension, cough, hyperkalemia
Renal failure in patients with renal artery stenosisFetal injuryAngioedema
Neutropenia, dysgeusia, and rash with captopril
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs)Prototype: Losartan (Diovan)
Other ARBsCandesartan (Atacand)Eprosartan (Teveten)Irbesartan (Avalide)Losartan (Hyzaar)
Olmesartan (Benicar)Telmisartan (Micardis)
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs)Prototype: Losartan (Diovan)
Mechanism of ActionBlocks the action of angiotensin II
Dilates arterioles and veins to reduce blood volume and BPPrevents pathologic changes in cardiac structure
Does not cause cough or significant hyperkalemia
UsesHypertension, heart failure, MI, and diabetic nephropathy
Prevention of MI, stroke, and death
Adverse EffectsRenal failure in patients with renal artery stenosis
HypotensionAngioedemaFetal harm
Ch43
Drugs
Acting
onthe
Renin-Angiotensin-A
ldosteroneSystem
Ch43
Drugs
Acting
onthe
Renin-Angiotensin-A
ldosteroneSystem
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
DIRECT RENIN INHIBITORS (DRIs)Prototype: Aliskiren (Tekturna)
DIRECT RENIN INHIBITORS (DRIs)Prototype: Aliskiren (Tekturna)
Mechanism of ActionBinds with renin and inhibits the formation of angiotensin I
UsesHypertension
Adverse EffectsAngioedema and cough
GI effects (diarrhea)Hyperkalemia
Fetal injury and death
ALDOSTERONE ANTAGONISTSPrototype: Eplerenone (Inspra)
Other Aldosterone AntagonistsSpironolactone
ALDOSTERONE ANTAGONISTSPrototype: Eplerenone (Inspra)
Mechanism of ActionBlocks aldosterone, increases excretion of sodium and water
Retention of potassiumReduces blood volume and blood pressure
Prevents cardiovascular remodeling
UsesHypertension, heart failure
Adverse EffectsHyperkalemia
Ch43
Drugs
Acting
onthe
Renin-Angiotensin-A
ldosteroneSystem
Ch43
Drugs
Acting
onthe
Renin-Angiotensin-A
ldosteroneSystem
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CALCIUM CHANNEL BLOCKERSNondihydropyridines
Prototypes: Verapamil (Calan) and Diltiazem(Cardizem)
CALCIUM CHANNEL BLOCKERSNondihydropyridines
Prototypes: Verapamil (Calan) and Diltiazem(Cardizem)
Mechanism of ActionBlock calcium channels in the heart and blood vesselsDilate peripheral arterioles to reduce blood pressure
Increase coronary perfusionBlock SA and AV nodes to reduce heart rate and contractility
Reduce force of myocardial contraction
UsesAngina, essential hypertension, cardiac dysrhythmias
Adverse EffectsConstipation, dizziness, facial flushing, peripheral edema, hypotension
Bradycardia, AV block, decreased cardiac contractilityChronic eczematous rash and gingival hyperplasia
Verapamil increases digoxin level by 60%
CALCIUM CHANNEL BLOCKERSDihydropyridine
Prototype: Amlodipine (Norvasc)
Other Dihydropyridine Calcium Channel BlockersNifedipine (Adalat, Procardia)
Nicardipine (Cardene)Isradipine (DynaCirc)Felodipine (Plendil)
Nimodipine (Nimotop)Nisoldipine (Sular)
CALCIUM CHANNEL BLOCKERSDihydropyridine
Prototype: Amlodipine (Norvasc)Mechanism of Action
Blocks calcium channels in the blood vesselsLittle effect on heart rate or contractility
Vasodilation in peripheral arterioles lowers blood pressureCalcium channel blockade in coronary arteries increases perfusion
UsesHypertension
Angina
Adverse EffectsHypotension, edema, flushing, dizziness, headache
Peripheral edema, gingival hyperplasia, chronic eczematous rashDoes not slow heart rate, as do verapamil and diltiazem
Ch44
CalciumChannelBlockers
Ch44
CalciumChannelBlockers
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
VASODILATORSPrototype: Hydralazine (Apresoline)
Other VasodilatorsBiDil (hydralazine and isosorbide dinitrate)
MinoxidilDiazoxide (Hyperstat IV)
Sodium nitroprusside (Nitropress)Angiotensin-converting enzymes (ACE) inhibitors
Angiotensin II receptor blockers (ARBs)Direct renin inhibitors (DRIs)
Calcium channel blockers (CCBs)Alpha-adrenergic blocking agents
Ganglionic blocking agentsAdrenergic neuron blocking agents
Centrally acting alpha2 agonistsNesiritide (Natrecor)
Drugs used for pulmonary artery hypertension
VASODILATORSPrototype: Hydralazine (Apresoline)
Mechanism of ActionSelective dilation of arterioles (mechanism unknown)
Decrease in peripheral resistance and arterial blood pressureIncrease in heart rate and myocardial contractility by reflex
UsesEssential hypertension, hypertensive crisis, heart failure
Adverse EffectsReflex tachycardia
Increased blood volumeSystemic lupus erythematosus–like syndromeHeadache, dizziness, weakness, and fatigue
CARDIAC (DIGITALIS) GLYCOSIDESPrototype: Digoxin (Lanoxin)
Positive Inotropic Agent for Heart Failure
Other Drugs Used to Treat Heart FailureDiuretics
ACE inhibitorsAngiotensin receptor blockers
Beta blockersAldosterone blockers
CARDIAC (DIGITALIS) GLYCOSIDESPrototype: Digoxin (Lanoxin)
Positive Inotropic Agent for Heart FailureMechanism of Action
Increases the force of ventricular contraction to increase cardiac outputInhibits Na1, K1-ATPase to increase Ca11 inside myocytes
Competes with K1 for binding to Na1, K1-ATPase↓ K → ↑ Na1, K1-ATPase inhibition → digoxin toxicityChanges electrical activity of heart and slows heart rate
Increased cardiac output → decreased sympathetic tone, increased urine production,and decreased release of renin
UsesHeart failure and dysrhythmias
Adverse EffectsAnorexia, nausea and vomiting, fatigue
Visual disturbances (blurry vision, yellow tinge, halos)Dysrhythmias
Digoxin toxicity (therapeutic level, 0.5 to 0.8 ng/mL)Hold if HR , 60 bpm or K1 is low
Inject slowly over 5 minutesGive Digibind for digoxin overdose
Ch45
VasodilatorsCh
47D
rugsfor
Heart
Failure
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CLASS I: SODIUM CHANNEL BLOCKERSPrototype: Procainamide (Procanbid)
Class IA Sodium Channel Blocker
Other Class IA Sodium Channel BlockersQuinidine
Disopyramide (Norpace)
CLASS I: SODIUM CHANNEL BLOCKERSPrototype: Procainamide (Procanbid)
Class IA Sodium Channel BlockerMechanism of Action
Blocks cardiac sodium channelsSlows conduction in the atria, ventricles, and His-Purkinje system
Delays depolarization
UsesAtrial and ventricular dysrhythmias
Adverse EffectsSystemic lupus erythematosus–like syndrome
Blood dyscrasiasQRS widening and prolongation
CLASS I: SODIUM CHANNEL BLOCKERSClass IB Sodium Channel Blocker
Prototype: Lidocaine (Xylocaine)
Other Sodium Channel–Blocking AntidysrhythmicsClass IB
Mexiletine (Mexitil)Phenytoin (Dilantin)
Class ICFlecainide (Tambocor)Propafenone (Rythmol)
Other Class IMoricizine (Ethmozine)
CLASS I: SODIUM CHANNEL BLOCKERSClass IB Sodium Channel Blocker
Prototype: Lidocaine (Xylocaine) Mechanism of Action
Blocks cardiac sodium channelsSlows conduction in the atria, ventricles, and His-Purkinje system
Reduces automaticity in the ventricles and His-Purkinje systemAccelerates repolarization
UsesShort-term therapy for ventricular dysrhythmias
Adverse EffectsNo significant impact on the ECG
Drowsiness, confusion, and paresthesiasToxic doses may produce convulsions and respiratory arrest
Ch48
Antidysrhythm
icD
rugsCh
48A
ntidysrhythmic
Drugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CLASS II: BETA BLOCKERSPrototype: Propranolol (Inderal)
Other Class II AgentsAcebutolol (Sectral)Esmolol (Brevibloc)
CLASS II: BETA BLOCKERSPrototype: Propranolol (Inderal)
Mechanism of ActionNonselective beta-adrenergic antagonist
Attenuates sympathetic stimulation of the heartBlocks both beta1 and beta2 receptorsReduces automaticity of the SA node
Reduces velocity of conduction through the AV node (prolongs PR interval)Reduces myocardial contractility
UsesSinus tachycardia, severe recurrent ventricular tachycardia
Exercise-induced tachydysrhythmiasParoxysmal atrial tachycardia provoked by emotion or exercise
Angina of effort
Adverse EffectsProlongs PR interval on the ECG
Bradycardia, heart failure, AV block, and sinus arrestHypotension, bronchospasm in patients with asthma
CLASS III: POTASSIUM CHANNEL BLOCKERSPrototype: Amiodarone (Cordarone, Pacerone)
Other Class III Agents Bretylium
Sotalol (Betapace) class II and class IIIDofetilide (Tikosyn)Ibutilide (Corvert)
CLASS III: POTASSIUM CHANNEL BLOCKERSPrototype: Amiodarone (Cordarone, Pacerone)
Mechanism of ActionDelays repolarization
Reduces automaticity in the SA node, reduces contractilityReduces conduction velocity in the AV node, ventricles, and His-Purkinje system
Dilates coronary and peripheral blood vessels
UsesRecurrent ventricular fibrillationUnstable ventricular tachycardia
Adverse EffectsPulmonary toxicities (pneumonitis and fibrosis)
Widening of the QRS complex, prolongation of the PR and QT intervalsSinus bradycardia, AV block, precipitation of heart failure, hypotension
Toxicities in pregnancyCorneal microdeposits, optic neuropathy
Blue-gray discoloration of the skinGI reactions (anorexia, nausea, vomiting)
CNS reactions (ataxia, dizziness, tremor, mood alterations, hallucinations)Hepatitis, thyroid dysfunction
Grapefruit juice increases levels to toxicity
Ch48
Antidysrhythm
icD
rugsCh
48A
ntidysrhythmic
Drugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CLASS IV: CALCIUM CHANNEL BLOCKERSPrototypes: Verapamil (Calan, Isoptin, Verelan)
Diltiazem (Cardizem, others)
Other Antidysrhythmic DrugsAdenosine (Adenocard)
Digoxin (Lanoxin)
CLASS IV: CALCIUM CHANNEL BLOCKERSPrototypes: Verapamil (Calan, Isoptin, Verelan)
Diltiazem (Cardizem, others)Mechanism of Action
Block calcium channels in the heartSlow SA node automaticity, delay AV node conduction
Reduce myocardial contractility
UsesAtrial fibrillation or atrial flutter
Supraventricular tachycardia
Adverse EffectsBradycardia, AV block, and heart failure
Hypotension, peripheral edema, and constipationCan elevate digoxin levels
Grapefruit juice increases levels to toxicity
HMG-CoA REDUCTASE INHIBITORS (STATINS)Prototype: Atorvastatin (Lipitor)
Other “Statins”Fluvastatin (Lescol)
Lovastatin (Mevacor, Altoprev)Pravastatin (Pravachol)Rosuvastatin (Crestor)Simvastatin (Zocor)
Cholestin (dietary supplement made from red yeast)
HMG-CoA REDUCTASE INHIBITORS (STATINS)Prototype: Atorvastatin (Lipitor)
Mechanism of ActionInhibits the enzyme (HMG-CoA) that synthesizes cholesterol
Increases the number of LDL receptors on liver cells to remove more LDLDecreases production of VLDLs and raises HDL levels
Stabilizes plaque, slows progression of coronary calcificationImproves endothelial function
Enhances the ability of blood vessels to dilateReduces the risk of thrombosis
Inhibits platelet deposition and aggregationMay increase bone formation
UsesHypercholesterolemia
Primary and secondary prevention of CV eventsPost MI therapy
Prevention of CV events in people with diabetesAdverse Effects
Headache, rash, GI complaintsMyopathy, increases CK levels, rhabdomyolysis, dark urine, renal failure
Hepatotoxicity, increases ALT and ASTRare peripheral neuropathy
FDA Pregnancy risk Category XDrug Interactions
Macrolide antibiotics, azole antifungalsHIV protease inhibitors, amiodarone, cyclosporine, and grapefruit juice raise some
statins to toxic levels
Ch48
Antidysrhythm
icD
rugsCh
49Prophylaxis
ofCoronaryH
eartD
isease
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
NICOTINIC ACIDPrototype: Nicotinic Acid (Niacor, Niaspan)
Drug CombinationsLovastatin/niacin (Advicor)Simvastatin/niacin (Simcor)
NICOTINIC ACIDPrototype: Nicotinic Acid (Niacor, Niaspan)
Mechanism of ActionReduces LDL and triglycerides
Increases HDL
UsesLowers triglycerides in patients at risk for pancreatitis
Dyslipidemia Reduces the risk of major coronary events
Reduces total mortality
Adverse EffectsFlushing and itching (take 325 mg ASA 30 minutes before dose)
Gastric upset, nausea, vomiting, diarrheaHepatotoxicity
May raise blood sugar in patients with diabetesMay increase incidence of gout
BILE-ACID SEQUESTRANTSPrototype: Colesevelam (WelChol)
Other AgentsCholestyramine (Questran)
Colestipol (Colestid)
BILE-ACID SEQUESTRANTSPrototype: Colesevelam (WelChol)
Mechanism of ActionBinds (sequesters) bile acids in the GI tract
Prevents the absorption and promotes their excretionForms insoluble complex with bile acids
Increases LDL receptorsSafest of all lipid-lowering drugs
UsesHypercholesterolemia
Often used in combination with statinApproved to control hyperglycemia in patients with type 2 diabetes
Adverse EffectsConstipation, bloating, indigestion
Interferes with absorption of other drugsMay impede absorption of fat-soluble vitamins
Ch49
ProphylaxisofCoronary
Heart
Disease
Ch49
ProphylaxisofCoronary
Heart
Disease
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
EZETIMIBE (ZETIA)Cholesterol-Lowering Drug
Drug CombinationsSimvastatin/ezetimibe (Vytorin)
EZETIMIBE (ZETIA)Cholesterol-Lowering Drug
Mechanism of ActionInhibits cholesterol absorption in the small intestineReduces LDL, triglycerides, and apolipoprotein B
Small increase in HDL
UsesHypercholesterolemia
Used in combination with statins
Adverse EffectsReports of myopathy, rhabdomyolysis, pancreatitis, and thrombocytopenia
May increase risk of liver damage when used with statins
FIBRIC ACID DERIVATIVES (FIBRATES)Prototype: Gemfibrozil (Lopid)
Other Fibric Acid DerivativesFenofibrate (TriCor, Antara, Lofibra, Triglide)
Fenofibric acid (TriLipix)—approved for use with statins
FIBRIC ACID DERIVATIVES (FIBRATES)Prototype: Gemfibrozil (Lopid)
Mechanism of ActionReduces triglycerides by lowering VLDL
Raises HDL levels
UsesHypertriglyceridemia
Adverse EffectsRash, nausea, abdominal pain, diarrhea
Gallstone formationMyopathy, liver injury
Increases warfarin levels, leading to hemorrhageDo not combine gemfibrozil with statins
Ch49
ProphylaxisofCoronary
Heart
Disease
Ch49
ProphylaxisofCoronary
Heart
Disease
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ORGANIC NITRATES (ANTIANGINAL AGENTS)Prototype: Nitroglycerin
Similar AgentsIsosorbide mononitrate
Isosorbide dinitrateAmyl nitrite
Other Antianginal AgentsBeta blockers
Calcium blockersRanolazine (Ranexa)
ORGANIC NITRATES (ANTIAGINAL AGENTS)Prototype: Nitroglycerin
Mechanism of ActionDilates veins, decreases venous return to the heart
Reduces ventricular filling and wall tension (preload)Reduces cardiac oxygen demand
UsesAngina, myocardial infarction
Adverse EffectsHeadache, orthostatic hypotension
Reflex tachycardiaTolerance to drug effect
Vasospasm if withdrawn abruptlyUse with sildenafil (Viagra), other drugs for erectile dysfunction may
lead to severe hypotension
ANTICOAGULANTSPrototype: Heparin
Low-Molecular-Weight Heparins (LMWH)Enoxaparin (Lovenox)Dalteparin (Fragmin)Tinzaparin (Innohep)
LMWH can be given on a fixed dose; does not require aPTT monitoring
Selective Factor Xa InhibitorsFondaparinux (Arixtra)
Rivaroxaban (Xarelto)
Direct Thrombin InhibitorsBivalirudin (Angiomax)
Lepirudin (Refludan)Argatroban
Desirudin (Ipravask)
ANTICOAGULANTSPrototype: HeparinMechanism of Action
Suppresses the formation of fibrin in veinsInactivates clotting factors thrombin and Xa
Anticoagulant effect develops quickly
UsesUsed for pulmonary embolism, evolving stroke, DVT
Open heart surgery, renal dialysisPrevention of postoperative thrombosisDisseminated intravascular coagulation
Acute myocardial infarction
MonitorActivated partial thromboplastin time (aPTT)
Normal aPTT: 40 seconds; therapeutic level: 60 to 80 seconds
Adverse EffectsBleeding—antidote is protamine sulfate
Heparin-induced thrombocytopenia (HIT)Decreased platelet count (,100,000/mm3) leads to thrombosis
Hypersensitivity reaction (fever, chills, urticaria)May be used during pregnancy
Ch50
Drugs
forAngina
PectorisCh
51A
nticoagulant,Antiplatelet,and
Thrombolytic
Drugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANTICOAGULANTPrototype: Warfarin (Coumadin, Jantoven)
Oral Anticoagulant
ANTICOAGULANTPrototype: Warfarin (Coumadin, Jantoven)
Mechanism of ActionSuppresses coagulation by reducing production of clotting factors
Antagonizes vitamin KInhibits vitamin K–dependent clotting factors
Blocks synthesis of factors VII, IX, X, and prothrombinEffect takes a few days
UsesLong-term prophylaxis of venous thrombosis and pulmonary embolism
Prevention of thromboembolism in patients with mechanical heart valvesPrevention of thrombosis in patients with atrial fibrillationPrevention of transient ischemic attacks and recurrent MI
MonitorProthrombin time (PT)—reported as INR
Goal INR for atrial fibrillation: 2-3Goal INR for mechanical valves: 3-4.5
Adverse EffectsHemorrhage—antidote is vitamin K (phytonadione)
Skin disorders, GI disturbances, red-orange color of urineIncreased risk of fractures with long-term use
Many drug-drug interactionsKeep intake of vitamin K foods constant
Fetal harm
ANTIPLATELET DRUGSPrototype: Aspirin
ANTIPLATELET DRUGSPrototype: AspirinMechanism of Action
Irreversible inhibition of COX-1 and COX-2Suppresses platelet aggregation
Decreases prostaglandin synthesisReduces the risk of arterial thrombosisReduces inflammation, pain, and fever
UsesIschemic stroke, transient ischemic attacks (TIAs)
Chronic stable angina, unstable anginaCoronary stenting, acute MI, previous MI
Primary prevention of MI
Adverse EffectsGastric distress (heartburn and nausea)
GI bleeding, gastric ulceration and perforationNot used in children because of the risk of Reye’s syndrome
Fetal harm (prolongs labor, premature closure of the patent ductus)Salicylism (tinnitus, sweating, headache, dizziness)
Hypersensitivity in patients with allergiesRenal impairment
Bleeding
Ch51
Anticoagulant,A
ntiplatelet,andThrom
bolyticD
rugsCh
51A
nticoagulant,Antiplatelet,and
Thrombolytic
Drugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANTIPLATELET DRUGSADENOSINE DIPHOSPHATE RECEPTOR (ADP)
ANTAGONISTSPrototype: Clopidogrel (Plavix)
Other, Similar AgentTiclopidine (Ticlid)—major adverse effects
ANTIPLATELET DRUGSADENOSINE DIPHOSPHATE RECEPTOR (ADP)
ANTAGONISTSPrototype: Clopidogrel (Plavix)
Mechanism of ActionBlocks ADP receptors so that platelets are unable to aggregate
UsesPrevents blockage of coronary artery stints
Reduces thrombotic events—MI, ischemic stroke, vascular death
Adverse EffectsDyspepsia, diarrhea, rash
Intracranial hemorrhage, GI bleedingRare thrombotic thrombocytopenia (TTP)
ANTIPLATELET DRUGSGLYCOPROTEIN llb/llla–RECEPTOR ANTAGONISTS
Prototype: Abciximab (RePro)
Other, Similar AgentsEptifibatide (Integrilin)Tirofiban (Aggrastat)
Dipyridamole (Persantine)Cilostazol (Pletal)
ANTIPLATELET DRUGSGLYCOPROTEIN llb/llla–RECEPTOR ANTAGONISTS
Prototype: Abciximab (RePro)Mechanism of Action
Causes reversible blockade of platelet GP IIb/IIIa receptorsInterferes with the final step in platelet aggregation
UsesPrevents ischemic events in patients with acute coronary syndrome
Used during percutaneous angioplasty
Adverse EffectsHemorrhage
Ch51
Anticoagulant,A
ntiplatelet,andThrom
bolyticD
rugsCh
51A
nticoagulant,Antiplatelet,and
Thrombolytic
Drugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
THROMBOLYTIC DRUGSPrototype: Alteplase (tPA)
Other, Similar AgentsStreptokinase (Streptase)Tenecteplase (TNKase)
Reteplase (Retavase)Urokinase (Abbokinase)
THROMBOLYTIC DRUGSPrototype: Alteplase (tPA)
Mechanism of ActionConverts plasminogen to plasmin
Plasmin is an enzyme that digests the fibrin matrix of clotsDissolves existing thrombi
Does not prevent thrombi from forming
UsesAcute myocardial infarction, pulmonary embolism, and ischemic stroke
Adverse EffectsBleeding
Intracranial hemorrhage
FERROUS SULFATEOral Iron Preparation
Other Oral Iron PreparationsFerrous fumarateFerrous gluconate
Carbonyl iron
FERROUS SULFATEOral Iron Preparation
Mechanism of ActionEssential to the function of hemoglobin and myoglobin
(oxygen-storing molecule of muscle)
UsesIron deficiency anemia (microcytic hypochromic anemia)
Adverse EffectsNausea, heartburn (pyrosis), bloating, constipation, diarrhea
May turn stool dark green or blackLiquid iron preparation stains teeth
Toxic to children (lethal dose is 2 to 10 grams)
Ch51
Anticoagulant,A
ntiplatelet,andThrom
bolyticD
rugsCh
54D
rugsfor
Deficiency
Anem
ias
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CYANOCOBALAMIN (VITAMIN B12)CYANOCOBALAMIN (VITAMIN B12)Mechanism of Action
Essential for synthesis of DNACatalyzes conversion of folic acid to its active form
UsesB12 deficiency, pernicious anemia
Macrocytic normochromic anemia (megaloblastic anemia)
Adverse EffectsHypokalemia
Never given IVFolic acid can mask the hematologic effects of B12 deficiency
FOLIC ACID (FOLATE)FOLIC ACID (FOLATE)Mechanism of Action
Essential for synthesis of DNA
UsesTreatment of folic acid deficiency (megaloblastic anemia)
Used prophylactically to prevent neural tube defects (NTDs)
Adverse EffectsDoes not correct neurologic consequences
Can correct anemia but may mask B12 deficiencyAlways give folic acid with B12
Ch54
Drugs
forD
eficiencyA
nemias
Ch54
Drugs
forD
eficiencyA
nemias
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ERYTHROPOIETIC GROWTH FACTORSPrototype: Epoetin Alfa
(Erythropoietin, Epogen, Procrit)
Other Erythropoietic Growth FactorsDarbepoetin Alpha (Aranesp)—long acting
Methoxy polyethylene glycol (Mircera)
ERYTHROPOIETIC GROWTH FACTORSPrototype: Epoetin Alfa
(Erythropoietin, Epogen, Procrit)Mechanism of Action
Stimulates production of red blood cells in the bone marrow
UsesAnemia of chronic renal failure
Anemia due to AIDS treatment with AZT (zidovudine)Anemia caused by chemotherapyAnemia in patients facing surgery
Adverse EffectsHypertension
Increase in cardiovascular events (heart failure, thrombosis, stroke and MI)Hemoglobin level should not exceed 12 g/dL
Rise in hemoglobin should not exceed 1 g/dL in 2 weeksRed cell aplasia (anemia due to autoimmune response)
LEUKOPOIETIC GROWTH FACTORSPrototype: Filgrastim (Neupogen)
Other Leukopoietic Growth FactorsPegfilgrastim (Neulasta)Sargramostim (Leukine)
LEUKOPOIETIC GROWTH FACTORSPrototype: Filgrastim (Neupogen)
Mechanism of ActionActs on bone marrow to increase production of neutrophils
UsesPatients undergoing myelosuppressive chemotherapy
Patients undergoing bone marrow transplantationHarvesting of peripheral blood progenitor cells
Severe chronic neutropeniaReduces risk of infection
Adverse EffectsBone pain, leukocytosis
Elevates uric acid levels, LDH, and alkaline phosphataseSplenomegaly
Ch55
Hem
atopoieticG
rowth
FactorsCh
55H
ematopoietic
Grow
thFactors
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
THROMBOPOIETIC GROWTH FACTORSPrototype: Oprelvekin (Neumega)
THROMBOPOIETIC GROWTH FACTORSPrototype: Oprelvekin (Neumega)
Mechanism of ActionStimulates production of platelets (thrombocytes)
UsesPatients undergoing myelosuppressive chemotherapy
Increases platelets to minimize thrombocytopenia
Adverse EffectsRetention of sodium and water by kidneys
Peripheral edemaTachycardia, atrial fibrillation, atrial flutter
Severe allergic reactionsConjunctival injection
ORAL AGENTS FOR TYPE 2 DIABETESBIGUANIDES
Prototype: Metformin (Glucophage, Fortamet, Glumetza, Riomet)
ORAL AGENTS FOR TYPE 2 DIABETESBIGUANIDES
Prototype: Metformin (Glucophage, Fortamet, Glumetza, Riomet)
Mechanism of ActionInhibits glucose production in the liver (gluconeogenesis)
Inhibits glucose absorption in the intestinesSensitizes insulin receptors on fat and skeletal muscleEnhances glucose uptake and metabolism by muscle
Lowers basal and postprandial blood sugar
UsesType 2 diabetes
Prevention of type 2 diabetesTreatment of polycystic ovary syndrome (PCOS)
Adverse EffectsDecreased appetite, nausea, diarrhea, and weight loss
Rare cases of lactic acidosisAvoid in patients with renal disease (Cr .1.4 mg/dL)
Avoid in patients with ethyl alcohol (ETOH) abuse, infection, liver disease, or CHFDiscontinue 48 hours prior to test with contrast medium to avoid lactic acidosis
Can reduce vitamin B12 and folic acid absorption
Ch55
Hem
atopoieticG
rowth
FactorsCh
56D
rugsfor
Diabetes
Mellitus
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ORAL AGENTS FOR TYPE 2 DIABETESSULFONYLUREAS
Prototype: Glipizide (Glucotrol, Glucotrol ER)
Other SulfonylureasGlyburide (DiaBeta, Micronase)
Glimepiride (Amaryl)
ORAL AGENTS FOR TYPE 2 DIABETESSULFONYLUREAS
Prototype: Glipizide (Glucotrol, Glucotrol ER)Mechanism of Action
Stimulates insulin release from the pancreas
UsesType 2 diabetes
Adverse EffectsHypoglycemia
Possible increased risk of sudden cardiac deathFetal harm
Disulfiram-like reaction when taken with ETOH
ORAL AGENTS FOR TYPE 2 DIABETESMEGLITINIDES
Prototype: Repaglinide (Prandin)
Other MeglitinideNateglinide (Starlix)
ORAL AGENTS FOR TYPE 2 DIABETESMEGLITINIDES
Prototype: Repaglinide (Prandin)Mechanism of Action
Stimulates pancreatic insulin release
UsesType 2 diabetes
Adverse EffectsHypoglycemia
Administer 30 minutes before a meal
Ch56
Drugs
forD
iabetesM
ellitusCh
56D
rugsfor
Diabetes
Mellitus
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ORAL AGENTS FOR TYPE 2 DIABETESTHIAZOLIDINEDIONES (GLITAZONES, TZDs)
Prototype: Rosiglitazone (Avandia)
Other TZDsPioglitazone (Actos)
ORAL AGENTS FOR TYPE 2 DIABETESTHIAZOLIDINEDIONES (GLITAZONES, TZDs)
Prototype: Rosiglitazone (Avandia)Mechanism of Action
Increases insulin sensitivity
UsesType 2 diabetes
Adverse EffectsMild headache and upper respiratory infections
Raises LDL levelsFluid retention—caution in patients with CHF
Hepatotoxicity—monitor ALTMay increase cardiovascular events
ORAL AGENTS FOR TYPE 2 DIABETESALPHA-GLUCOSIDASE INHIBITORS
Prototype: Acarbose (Precose)
Other Alpha-Glucosidase InhibitorMiglitol (Glyset)
ORAL AGENTS FOR TYPE 2 DIABETESALPHA-GLUCOSIDASE INHIBITORS
Prototype: Acarbose (Precose)Mechanism of Action
Delays absorption of carbohydratesLowers postprandial blood glucose levels
UsesType 2 diabetes
Adverse EffectsFlatulence, cramps, abdominal distention, and diarrhea
Hypoglycemia, liver dysfunction
Ch56
Drugs
forD
iabetesM
ellitusCh
56D
rugsfor
Diabetes
Mellitus
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ORAL AGENTS FOR TYPE 2 DIABETESGLIPTINS
Prototype: Sitagliptin (Januvia)
ORAL AGENTS FOR TYPE 2 DIABETESGLIPTINS
Prototype: Sitagliptin (Januvia)Mechanism of Action
Increases the incretin system Inhibits the enzyme DPP-4, which breaks down incretin hormonesSuppresses glucagon release from the alpha cells of the pancreas
Stimulates insulin release from the beta cells of the pancreasTurns off glucose production in the liver
UsesType 2 diabetes
Adverse EffectsNasal inflammation, upper respiratory tract infection
Minimal hypoglycemia
NEW INJECTABLE DRUGS FOR DIABETESINCRETIN MIMETIC
Prototype: Exenatide (Byetta)
NEW INJECTABLE DRUGS FOR DIABETESINCRETIN MIMETIC
Prototype: Exenatide (Byetta)Mechanism of Action
Action similar to natural incretins released in the GI tractSlows gastric emptying
Stimulates glucose-dependent release of insulinInhibits postprandial release of glucagon
Suppresses appetiteDecreases postprandial blood glucose
UsesType 2 diabetes
Adverse EffectsHypoglycemia
Nausea, vomiting, and diarrheaRare incidences of pancreatitis
Weight loss
Ch56
Drugs
forD
iabetesM
ellitusCh
56D
rugsfor
Diabetes
Mellitus
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
NEW INJECTABLE DRUGS FOR DIABETESAMYLIN MIMETIC
Prototype: Pramlintide (Symlin)
NEW INJECTABLE DRUGS FOR DIABETESAMYLIN MIMETIC
Prototype: Pramlintide (Symlin)Mechanism of Action
Mimics the effects of amylin (hormone made in the pancreas)Reduces postprandial levels of glucose
Delays gastric emptyingSuppresses glucagon secretionIncreases the sense of satiety
Enhances the effects of mealtime insulin
UsesType 1 and type 2 diabetes
Adverse EffectsHypoglycemia when combined with other agents
NauseaInjection site reactions
INJECTABLE DRUGS FOR DIABETESGLUCAGON
INJECTABLE DRUGS FOR DIABETESGLUCAGON
Mechanism of ActionHormone that increases plasma levels of glucose
Opposite effect of insulin
UsesTreats hypoglycemia from insulin overdose
Used only if intravenous glucose is not available
Adverse EffectsNausea and vomiting
Place patient on side after administration
Ch56
Drugs
forD
iabetesM
ellitusCh
56D
rugsfor
Diabetes
Mellitus
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
THYROID HORMONESPrototype: Levothyroxine (Synthroid, Levoxyl)
Synthetic Preparation of T4
Other Thyroid Hormone PreparationsLiothyronine (Cytomel, Triostat) T3
Liotrix (Thyrolar) T3, T4 combinationArmour Thyroid—desiccated animal thyroid glands
THYROID HORMONESPrototype: Levothyroxine (Synthroid, Levoxyl)
Synthetic Preparation of T4Mechanism of Action
Converted to T3 in the bodyThyroid hormone replacement
UsesHypothyroidism
Adverse EffectsThyrotoxicosis if dosage is excessive
Tachycardia, angina, nervousness, insomniaHyperthermia, sweating, and tremor
Increases warfarin levelsTakes about 1 month to reach plateau
Take on an empty stomachDo not mix with calcium or iron
ANTITHYROID DRUGSPrototype: Propylthiouracil (PTU)
Other Antithyroid DrugsMethimazole (Tapazole)Radioactive iodine (131I)
Nonradioactive iodine—(Lugol’s solution)Sodium iodide (IV)
Potassium iodide (Thyro-Block)Propranolol (Inderal) suppresses tachycardia
ANTITHYROID DRUGSPrototype: Propylthiouracil (PTU)
Mechanism of ActionInhibits thyroid hormone synthesis
Inhibits conversion of T4 to T3 in the periphery
UsesHyperthyroidism, Graves’ disease
Thyrotoxic crisis
Adverse EffectsAgranulocytosis, hypothyroidism
Fetal harm, rash, nausea, arthralgia, headacheDizziness, paresthesias, and liver injury
May take 6 to 12 months to develop
Ch57
Drugs
forThyroidD
isordersCh
57D
rugsforThyroid
Disorders
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ERECTILE DYSFUNCTION DRUGSPDE-5 Inhibitors
Prototype: Sildenafil (Viagra)
Other Erectile Dysfunction DrugsTadalafil (Cialis)
Vardenafil (Levitra)Papaverine plus phentolamine injection
Alprostadil (prostaglandin E1)
ERECTILE DYSFUNCTION DRUGSPDE-5 Inhibitors
Prototype: Sildenafil (Viagra)Mechanism of Action
Enhances the normal erectile response to sexual stimuli by inhibiting PDE-5
UsesErectile dysfunction
Adverse EffectsHypotension, priapism
Nonarteritic ischemic optic neuropathy (NAION)Sudden hearing loss, dizziness, vertigo, tinnitusHeadache, flushing, dyspepsia, nasal congestion
Visual changes (blue color tinge, light sensitivity, blurring)Use with nitrates and alpha blockers leads to hypotension
DRUGS FOR BENIGN PROSTATIC HYPERTROPHY (BPH)5-alpha-Reductase Inhibitors
Prototype: Finasteride (Proscar)
Other 5-alpha Reductase InhibitorDutasteride (Avodart)
Alpha1-Adrenergic AntagonistsTerazosin (Hytrin)
Doxazosin (Cardura)Tamsulosin (Flomax)—used for BPH onlyAlfuzosin (Uroxatral)—used for BPH only
Other Drugs for BPHSaw palmetto
Tolterodine (Detrol)PDE-5 inhibitors
Botox
DRUGS FOR BENIGN PROSTATIC HYPERTROPHY (BPH)5-alpha-Reductase Inhibitors
Prototype: Finasteride (Proscar)Mechanism of Action
Reduces levels of dihydrotestosterone (DHT)Promotes regression of prostate epithelial tissueReduces mechanical obstruction of the urethra
Adverse EffectsReduces ejaculate volume and libidoGynecomastia (breast enlargement)
Reduces prostate-specific antigen (PSA)May mask an elevated PSA
Benefits develop slowly over 6 to 12 months
Ch65
Drugs
forErectile
Dysfunction
andBenign
ProstaticH
yperplasiaCh
65D
rugsfor
ErectileD
ysfunctionand
BenignProstatic
Hyperplasia
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
LIVE VIRUS VACCINESVaricella (Varivax)
Oral Polio Vaccine (OPV) not used in the United States
Measles, Mumps, and Rubella Virus Vaccine (MMR)
Live Influenza Attenuated Vaccine (LIAV)
Yellow fewer vaccine
Zoster vaccine (Zostavax)
Rotavirus vaccine (Rotarix, Rota Teq)
LIVE VIRUS VACCINESLive virus vaccines are contraindicated in pregnancyGive with caution in immunocompromised patients
IMMUNOSUPPRESSANTSPrototype: Cyclosporine
(Sandimmune, Gengraf, Neoral)
Other ImmunosuppressantsTacrolimus (Prograf)
Sirolimus (Rapamune)GlucocorticoidsCytotoxic drugs
Antibodies
IMMUNOSUPPRESSANTSPrototype: Cyclosporine
(Sandimmune, Gengraf, Neoral)Mechanism of Action
Suppresses production of inflammatory cellsReduces B cells and cytotoxic T cells
UsesPrevents rejection of organ transplants
Adverse EffectsNephrotoxicity, infection, hepatotoxicity, lymphomas
Hypertension, tremor, hirsutism, leukopenia Gingival hyperplasia, gynecomastia
Anaphylaxis, fetal harm
Ch67
ChildhoodIm
munization
Ch68
Imm
unosuppressants
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
FIRST-GENERATION H1 ANTAGONISTSAntihistamines
Prototype: Diphenhydramine (Benadryl)
Other First-Generation AntihistaminesBrompheniramine
Chlorpheniramine (Chlor-Trimeton)DexchlorpheniramineClemastine (Tavist)
Promethazine (Phenergan)Hydroxyzine (Vistaril)
FIRST-GENERATION H1 ANTAGONISTSAntihistamines
Prototype: Diphenhydramine (Benadryl)Mechanism of Action
Blocks H1 receptorsBlocks some muscarinic receptors
Reduces actions of histamineReduces flushing, itching, and secretion of mucus
UsesSeasonal allergic rhinitis, urticaria, severe allergy, motion sickness, insomnia
Cold symptoms, sleep aid, mild transfusion reactions, allergic reactions
Adverse EffectsSedation, confusion, fatigue
Paradoxical excitation can occurGastrointestinal disturbances
Anticholinergic effects (BUDCAT)
SECOND-GENERATION (NONSEDATING) H1ANTAGONISTS
Prototype: Loratadine (Claritin)
Antihistamine
Other Second-Generation Nonsedating H1Antagonists
Desloratadine (Clarinex)Fexofenadine (Allegra)
Cetirizine (Zyrtec)Levocetirizine (Xyzal)
Azelastine (Astelin) nasal spray
SECOND-GENERATION (NONSEDATING) H1ANTAGONISTS
Prototype: Loratadine (Claritin)
AntihistamineMechanism of Action
Blocks H1 receptorsReduces actions of histamine
Reduces flushing, itching, secretion of mucusDoes not cross brain-blood barrier to cause sedation
UsesAllergic rhinitis, urticaria, and mild transfusion reactions
Adverse EffectsReduce dose if hepatic or renal impairment occurs
Cetirizine (Zyrtec) may cause mild sedation in some patients
Ch69
Antihistam
inesCh
69A
ntihistamines
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CYCLOOXYGENASE INHIBITORSNonsteroidal Anti-inflammatory Drug (NSAID)
Prototype: Aspirin
CYCLOOXYGENASE INHIBITORSNonsteroidal Anti-inflammatory Drug (NSAID)
Prototype: AspirinMechanism of Action
Irreversible inhibition of cyclooxygenase (COX-1 and COX-2)Suppresses platelet aggregation
Decreases prostaglandin synthesisReduces inflammation, pain, and fever
UsesSuppression of inflammation
AnalgesiaReduction of fever in adults
DysmenorrheaSuppression of platelet aggregation to protect against MI and stroke
Prevention of colorectal cancer Possible protection against Alzheimer’s disease
Adverse EffectsGastric distress (heartburn and nausea)
GI bleeding, gastric ulceration and perforationNot used in children because of the risk of Reye’s syndrome
Fetal harm (prolongs labor, premature closure of the patent ductus)Salicylism (tinnitus, sweating, headache, dizziness)
Hypersensitivity in patients with allergiesRenal impairment
Bleeding
CYCLOOXYGENASE INHIBITORSFirst Generation—Nonaspirin NSAIDsPrototype: Ibuprofen (Advil, Motrin)
Other NSAIDsFenoprofen (Nalfon)
Flurbiprofen (Ansaid)Ketoprofen
Naproxen (Aleve, Anaprox, Naprelan, Naprosyn)Oxaprozin (Daypro)
Diclofenac (Voltaren, Cataflam)—risk of liver failureVoltaren Gel and Flector Patch
Diclofenac Plus Misoprostol (Arthrotec)Diflunisal (Dolobid)
EtodolacIndomethacin (Indocin)
Ketorolac (Toradol), available IM or IVMefenamic acid (Ponstel)
MeclofenamateMeloxicam (Mobic)
NabumetonePiroxicam (Feldene)Sulindac (Clinoril)Tolmetin (Tolectin)
CYCLOOXYGENASE INHIBITORSFirst Generation—Nonaspirin NSAIDs
Prototype: Ibuprofen (Advil, Motrin)Mechanism of Action
Reversible inhibition of COX-1 and COX-2Inhibits prostaglandin synthesis
Has anti-inflammatory, analgesic, and antipyretic actions
UsesFever, pain, arthritis, dysmenorrhea
Closure of the ductus arteriosus in preterm infants
Adverse EffectsBleeding, gastric ulceration, renal impairment
Cross-hypersensitivity with aspirinMay precipitate Reye’s syndrome
Fetal harmRisk of MI and stroke
Ch70
CyclooxygenaseInhibitors:N
SAID
sand
Acetam
inophenCh
70Cyclooxygenase
Inhibitors:NSA
IDs
andA
cetaminophen
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
CYCLOOXYGENASE INHIBITORSecond-Generation NSAID (COX-2 Inhibitor)
Prototype: Celecoxib (Celebrex)
CYCLOOXYGENASE INHIBITORSecond-Generation NSAID (COX-2 Inhibitor)
Prototype: Celecoxib (Celebrex)Mechanism of Action
Selective inhibition of COX-2Decreases prostaglandin synthesis at the site of injury
Reduces pain and inflammation Spares COX-1 inhibition
Minimal gastric, renal, and platelet effect
UsesOsteoarthritis, rheumatoid arthritis, dysmenorrhea
Acute pain
Adverse EffectsDyspepsia, mild renal impairment
Not used in patients with sulfonamide allergyPremature closure of ductus arteriosus
No inhibition of platelets Increased risk of MI and stroke
ACETAMINOPHEN (TYLENOL)Analgesic and Antipyretic
ACETAMINOPHEN (TYLENOL)Analgesic and Antipyretic
Mechanism of ActionReduces prostaglandin synthesis in the CNS
Has no anti-inflammatory properties
UsesPain and fever
Preferred in childrenNo GI injury, no effect on platelets or kidneys
Adverse EffectsToxic metabolite builds up in ETOH abusers
Hepatic necrosis can occurMaximum dose is 4 grams/day
Acetylcysteine (Mucomyst) given for overdoseInhibits metabolism of warfarin (risk of bleeding)
Ch70
CyclooxygenaseInhibitors:N
SAID
sand
Acetam
inophenCh
70Cyclooxygenase
Inhibitors:NSA
IDs
andA
cetaminophen
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
GLUCOCORTICOIDSShort Acting
CortisoneHydrocortisone
Intermediate ActingPrednisone
PrednisoloneMethylprednisone
Triamcinolone
Long ActingBetamethasoneDexamethasone
GLUCOCORTICOIDSMechanism of Action
Suppress immune responses and inflammationInhibit prostaglandins, leukotrienes, and histamine
Suppress phagocytes and lymphocytes
UsesRheumatoid arthritis, SLE, inflammatory bowel disease
Bursitis, osteoarthritis, anaphylaxis, asthmaSkin disorders, neoplasms, suppression of allograft rejection
Prevention of respiratory distress syndrome (RDS) in preterm infantsReplacement therapy for patients with Addison’s disease
Adverse EffectsAdrenal insufficiency resulting from suppression of HPA axis
Osteoporosis, infection, glucose intolerance (increases blood sugar)Myopathy, sodium and water retention, potassium loss
Growth retardation, mood changesCataracts, glaucoma
Peptic ulcer disease, iatrogenic Cushing’s syndromeFetal harm
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS(DMARDs I)
Prototype: Methotrexate (Rheumatrex, Trexall) Other DMARDs ISulfasalazine (Azulfidine)
Leflunomide (Arava)Hydroxychloroquine (Plaquenil)
DMARDs IIEtanercept (Enbrel)
Infliximab (Remicade)Adalimumab (Humira)Rituximab (Rituxan)Abatacept (Orencia)
DMARDs IIIPenicillamine (Cuprimine)
Azathioprine (Imuran)Cyclosporine
Anakinra (Kineret)Protein A column (Prosorba)
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS(DMARDs I)
Prototype: Methotrexate (Rheumatrex, Trexall)Mechanism of Action
Blocks conversion of folic acid to its active formReduces joint destruction, retards disease progression
Takes 3 to 5 months to see effect
UsesRheumatoid arthritis, non-Hodgkin’s lymphoma
Lymphocytic leukemia, psoriasis, and Crohn’s disease
Adverse EffectsBone marrow suppression, hepatic fibrosisGI ulceration, pneumonitis, and fetal harm
Ch71
Glucocorticoids
inN
onendocrineD
iseasesCh
72D
rugTherapy
ofRheumatoid
Arthritis
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
DRUGS FOR HYPERURICEMIAPrototype: Allopurinol (Zyloprim)
Other Drugs for HyperuricemiaProbenecid
Sulfinpyrazone (Anturane)
Drugs for Acute Gouty ArthritisNSAIDs
GlucocorticoidsColchicine (GI toxicities)
DRUGS FOR HYPERURICEMIAPrototype: Allopurinol (Zyloprim)
Mechanism of ActionInhibits uric acid formation
UsesChronic tophaceous gout
Hyperuricemia secondary to chemotherapyNot useful for acute gouty attacks
Adverse EffectsHypersensitivity syndrome
Nausea, vomiting, abdominal discomfortDrowsiness, headache, metallic taste
Cataracts with prolonged use (.3 years)
BISPHOSPHONATESPrototype: Alendronate (Fosamax)
Other BisphosphonatesRisedronate (Actonel)Ibandronate (Boniva)Tiludronate (Skelid)
Etidronate (Didronel)Zoledronate (Reclast, Zometa)
Other Drugs Used to Treat OsteoporosisSelective Estrogen Receptor Modulators (SERMs)
Raloxifene (Evista)
Parathyroid HormoneTeriparatide (Forteo)
BISPHOSPHONATESPrototype: Alendronate (Fosamax)
Mechanism of ActionSuppresses resorption of bone
Reduces both the number and activity of osteoclasts
UsesPostmenopausal osteoporosis
Osteoporosis in menGlucocorticoid-induced osteoporosis
Paget’s disease of the bone
Adverse EffectsEsophagitis
Musculoskeletal pain, ocular problemsOsteonecrosis of the jaw
Atrial fibrillation
Ch73
Drug
TherapyofG
outCh
74D
rugsA
ffectingCalcium
Levelsand
BoneM
ineralization
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANTI-INFLAMMATORY DRUGS FOR ASTHMAINHALED CORTICOSTEROIDS (ICSs)
Prototype: Fluticasone Propionate (Flovent)
Other Inhaled CorticosteroidsBeclomethasone dipropionate (QVAR)
Budesonide (Pulmicort Turbohaler, Pulmicort Respules)Flunisolide (AeroBid)
Mometasone furoate (Asmanex Twisthaler)Triamcinolone acetonide (Azmacort)
Combination ICSs and Long-Acting Beta2 AgonistsFluticasone and salmeterol (Advair)
Budesonide and formoterol (Symbicort)
ANTI-INFLAMMATORY DRUGS FOR ASTHMAINHALED CORTICOSTEROIDS (ICSs)
Prototype: Fluticasone Propionate (Flovent)Mechanism of Action
Suppresses the inflammation of asthmaDecreases leukotrienes, histamine, and prostaglandins
Decreases eosinophils and leukocytesReduces edema of the airway and mucus production
Reduces bronchial hyperactivityIncreases number of beta2 receptors
Increases responsiveness to beta2 agonists
UsesControl of asthma
Administered on a fixed scheduleTakes 2-8 days to see an effect, maximum benefit in 4-6 weeks
Adverse EffectsOropharyngeal candidiasis—rinse mouth after use
Minimal adrenal suppression and bone lossSlows growth but does not reduce adult height
Slight increased risk of cataracts, glaucoma, and osteoporosis
ANTI-INFLAMMATORY DRUGS FOR ASTHMALEUKOTRIENE MODIFIERS
Prototype: Montelukast (Singulair)
Other Leukotriene ModifiersZileuton (Zyflo)—associated with rare liver injury
Zafirlukast (Accolate)—associated with rare liver injury
ANTI-INFLAMMATORY DRUGS FOR ASTHMALEUKOTRIENE MODIFIERS
Prototype: Montelukast (Singulair)Mechanism of Action
Blocks leukotriene receptorsReduces inflammation, bronchoconstriction, and edema
Decreases secretion of mucusReduces eosinophils and other inflammatory cells
Reduces dosage of inhaled corticosteroids
UsesControl of asthma (not used as first-line therapy)
Prevention of exercise-induced bronchospasmAllergic rhinitis
Not used for rescue
Adverse EffectsGI upset
Delayed effectPossible rare neuropsychiatric effects (mood changes, suicidal thoughts)
Ch75
Drugs
forAsthm
aCh
75D
rugsforA
sthma
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANTI-INFLAMMATORY DRUGS FOR ASTHMAPrototype: Cromolyn (Intal)
ANTI-INFLAMMATORY DRUGS FOR ASTHMAPrototype: Cromolyn (Intal)
Mechanism of ActionSuppresses inflammation, prevents release of histamine
Stabilizes mast cell membraneNot a bronchodilator
UsesControl of asthma
Must be given on a fixed schedule (not used for rescue)Prevents exercise-induced bronchospasm
Allergic rhinitis (intranasal cromolyn)
Adverse EffectsSafest of all antiasthma medications
Rarely, can cause cough or bronchospasm
BRONCHODILATORSBETA2-ADRENERGIC AGONISTS (Inhaled Short-Acting Agents)
Prototype: Albuterol (Proventil, Ventolin, Accuneb)
Other Beta2-Adrenergic AgonistLevalbuterol (Xopenex, Xopenex HFA)
Oral Beta2-Adrenergic AgonistsAlbuterol (generic) tablets or syrup
Albuterol (VoSpire ER)Terbutaline (Brethine)
(Inhaled beta2 agents are preferred)
BRONCHODILATORSBETA2-ADRENERGIC AGONISTS(Inhaled Short-Acting Agents)
Prototype: Albuterol (Proventil, Ventolin, Accuneb)Mechanism of Action
Activation of beta2-adrenergic receptors in the lungPromotes bronchodilation
Rapid onset of action for rescue breathingSuppresses histamine release in the lung
Increases ciliary motility
UsesRapid relief of asthma symptoms
Adverse EffectsTachycardia, angina, and tremor
Ch75
Drugs
forAsthm
aCh
75D
rugsforA
sthma
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
BRONCHODILATORSBETA2-ADRENERGIC AGONISTS (Inhaled Long-Acting Agents)
Prototype: Salmeterol (Serevent)
Other Long-Acting Inhaled Beta2-Adrenergic AgonistsFormoterol (Foradil)
Arformoterol (Brovana)
BRONCHODILATORSBETA2-ADRENERGIC AGONISTS (Inhaled Long-Acting Agents)
Prototype: Salmeterol (Serevent)Mechanism of Action
Activates beta2-adrenergic receptors in the lungPromotes bronchodilation
Suppresses histamine release in the lungIncreases ciliary motility
UsesAsthma
Should not be used aloneShould be used in conjunction with an ICS
Adverse EffectsEffect is delayed by 20 to 30 minutesNot to be used for rescue breathing
Tachycardia, angina, tremor, and leg cramps
BRONCHODILATORSMETHYLXANTHINES
Prototype: Theophylline
Other MethylxanthinesAminophylline
BRONCHODILATORSMETHYLXANTHINES
Prototype: TheophyllineMechanism of Action
Produces bronchodilation by relaxing bronchi
UsesAsthma
(Beta2 agonists and inhaled corticosteroids preferred)
Adverse EffectsNarrow therapeutic range (5-15 mcg/mL)
Dysrhythmias, ventricular fibrillationConvulsions, cardiorespiratory collapse, and death
Many drug-drug reactions
Ch75
Drugs
forAsthm
aCh
75D
rugsforA
sthma
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
INTRANASAL GLUCOCORTICOIDS (ICSs)Prototype: Fluticasone (Flonase)
Other Intranasal GlucocorticoidsBeclomethasone (Beconase AQ)Budesonide (Rhinocort Aqua)
Flunisolide (Nasarel)Mometasone (Nasonex)
Triamcinolone (Nasacort AQ)
Other Drugs Used for Allergic RhinitisOral and nasal antihistamines
Intranasal cromolyn sodium (NasalCrom)Topical sympathomimetics (Oxymetazoline-Afrin)
Oral sympathomimetics (phenylephrine, pseudoephedrine)Ipratropium bromide (Atrovent) nasal spray
Montelukast (Singulair)
INTRANASAL GLUCOCORTICOIDS (ICSs)Prototype: Fluticasone (Flonase)
Mechanism of ActionAnti-inflammatory actions suppress symptoms of allergic rhinitis
Prevent or suppress congestion, rhinorrhea, sneezing, nasal itching
UsesSeasonal and perennial rhinitis
Adverse EffectsDrying of the nasal mucosa, burning or itching
Sore throat, epistaxis (nose bleed), and headache
ANTITUSSIVESPrototype: Dextromethorphan
Nonopioid Antitussive
Other Nonopioid AntitussivesDiphenhydramine (Benadryl)
Benzonatate (Tessalon)
Opioid AntitussivesCodeine
Hydrocodone
ANTITUSSIVESPrototype: Dextromethorphan
Nonopioid AntitussiveMechanism of Action
Acts in the CNS to suppress coughElevates the cough threshold
UsesAcute cough
Adverse EffectsMild inebriation and mind-body dissociation when abused
Can increase analgesic response to morphine
Ch76
Drugs
forAllergic
Rhinitis,Cough,andColds
Ch76
Drugs
forAllergic
Rhinitis,Cough,andColds
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
HISTAMINE2-RECEPTOR ANTAGONISTPrototype: Cimetidine (Tagamet)
Other Histamine2-Receptor AntagonistsRanitidine (Zantac)Famotidine (Pepcid)
Nizatidine (Axid)
HISTAMINE2-RECEPTOR ANTAGONISTPrototype: Cimetidine (Tagamet)
Mechanism of ActionBlocks H2 receptors on parietal cells of the stomach
Reduces volume of gastric juice and hydrogen ion content
UsesGastric and duodenal ulcers
Gastroesophageal reflux disease (GERD)Treatment of Zollinger-Ellison syndrome
Aspiration pneumonitisHeartburn, acid indigestion, and sour stomach
Adverse EffectsSignificant side effects are uncommon
Antiandrogenic effectsConfusion, hallucinations, CNS depression or excitation
Pneumonia
PROTON PUMP INHIBITORS (PPIs)Prototype: Omeprazole (Prilosec)
Other PPIsLansoprazole (Prevacid)Rabeprazole (Aciphex)Pantoprazole (Protonix)Esomeprazole (Nexium)
Other Antiulcer DrugsSucralfate (Carafate)
Misoprostol (Cytotec)Antacids
Combination Drugs for Helicobacter pylori–associated ulcersHelidacPylera
Prevpac
PROTON PUMP INHIBITORS (PPIs)Prototype: Omeprazole (Prilosec)
Mechanism of ActionInhibits the enzyme that generates acid production
UsesDuodenal and gastric ulcers, erosive esophagitis
GERD, dyspepsiaZollinger-Ellison syndrome
Adverse EffectsHeadache, diarrhea, nausea, and vomiting
Gastric cancer, and hip fractures
Ch77
Drugs
forPeptic
Ulcer
Disease
Ch77
Drugs
forPeptic
Ulcer
Disease
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANTIEMETIC DRUGSSerotonin-Receptor Antagonists
Prototype: Ondansetron (Zofran)
Other Serotonin-Receptor AntagonistsGranisetron (Kytril)
Dolasetron (Anzemet)Palonosetron (Aloxi)
Other Agents Used for NauseaGlucocorticoids
Aprepitant (Emend)Benzodiazepines
ANTIEMETIC DRUGSSerotonin-Receptor Antagonists
Prototype: Ondansetron (Zofran)Mechanism of Action
Suppresses emesis by blocking 5-HT3 receptors in the chemoreceptor trigger zone (CTZ)
UsesReduces nausea and vomiting caused by
chemotherapy, radiation therapy, and anesthesia (postoperatively)
Adverse EffectsHeadache, diarrhea, and dizziness
ANTIEMETIC DRUGSDopamine Antagonists
Prototype: Prochlorperazine (Compazine)
Other Dopamine AntagonistsPhenothiazines
Chlorpromazine (Thorazine)Perphenazine (Trilafon)
Promethazine (Phenergan)
ButyrophenonesHaloperidol (Haldol)Droperidol (Inapsine)
Metoclopramide (Reglan)
CannabinoidsDronabinol (Marinol)Nabilone (Cesamet)
ANTIEMETIC DRUGSDopamine Antagonists
Prototype: Prochlorperazine (Compazine)Mechanism of Action
Suppresses emesis by blocking dopamine2 receptors in the CTZ
UsesNausea and vomiting
Used after surgery, cancer chemotherapy, or other conditions
Adverse Effects Extrapyramidal reactions, anticholinergic effects
Hypotension and sedation
Ch79
Other
GastrointestinalD
rugsCh
79O
therG
astrointestinalDrugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
PROKINETIC AGENTSPrototype: Metoclopramide (Reglan)
PROKINETIC AGENTSPrototype: Metoclopramide (Reglan)
Mechanism of ActionSuppresses emesis by blocking receptors for dopamine and serotonin in the
chemoreceptor trigger (CTZ)Increases upper GI motility by enhancing the actions of acetylcholine
UsesSuppresses postoperative nausea and vomiting
Suppresses emesis associated with chemotherapy, radiation therapy, toxinsand opioids
Relieves diabetic gastroparesisSuppresses gastroesophageal reflux disease (GERD)
Adverse EffectsSedation and diarrhea
Extrapyramidal reactions, especially in children
HYDROXYZINE (VISTARIL, ATARAX)Antiemetic Drug
Anticholinergic-Antihistamine
HYDROXYZINE (VISTARIL, ATARAX)Antiemetic Drug
Anticholinergic-AntihistamineMechanism of Action
Blocks histaminergic and cholinergic receptors
UsesNausea
Adverse EffectsSedation, blurry vision, urinary retention, dry mouth
Ch79
Other
GastrointestinalD
rugsCh
79O
therG
astrointestinalDrugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
PENICILLINS (PCNs)Narrow-Spectrum Penicillin (Penicillinase Sensitive)
Beta-Lactam Antibiotic
Prototype: Benzylpenicillin (Penicillin G)
Parenteral PCN G (three salts)(1) Potassium PCN G (IM or IV)
(2) Procaine PCN G (never used IV)(3) Benzathine PCN G (never used IV)
Prescribed in units (1 unit = 0.6 mg)
Oral PCNPenicillin V (Veetids)
PENICILLINS (PCNs)Narrow-Spectrum Penicillin (Penicillinase Sensitive)
Beta-Lactam Antibiotic
Prototype: Benzylpenicillin (Penicillin G)Mechanism of Action
Disruption of the bacterial cell wall
UsesParenteral antibiotic treats gram-positive and gram-negative
Streptococcus and Neisseria organisms, anaerobes, and othersDrug of choice for syphilis
Adverse EffectsAllergic reaction, pain at site of injection
NeurotoxicitiesDo not mix PCN with aminoglycosides in IV solutions
ANTISTAPHYLOCCAL PENICILLINSPenicillinase-Resistant Penicillins
(PCNs that cannot be inactivated by bacterial beta-lactamases)
Prototype: Nafcillin (Unipen)
Other Antistaphyloccal PenicillinsOxacillin
Dicloxacillin Methicillin (no longer available)
ANTISTAPHYLOCCAL PENICILLINSPenicillinase-Resistant Penicillins
(PCNs that cannot be inactivated by bacterial beta-lactamases)
Prototype: Nafcillin (Unipen)Mechanism of Action
Disruption of the bacterial cell wall
UsesTreats infections caused by penicillinase-producing strains of Staphylococcus
(ie, S. aureus, S. epidermidis)
Adverse EffectsAllergic reaction, GI effects
Thrombophlebitis, hypokalemia
Ch83
Drugs
ThatWeaken
theBacterialCellW
allICh
83D
rugsThatW
eakenthe
BacterialCellWallI
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
AMINOPENICILLINSBroad-Spectrum Antibiotics
Prototype: Amoxicillin
Other AminopenicillinsAmpicillin
(Amoxicillin is preferred for oral therapy)
AMINOPENICILLINSBroad-Spectrum Antibiotics
Prototype: AmoxicillinMechanism of Action
Disruption of the bacterial cell wall
UsesSame antimicrobial spectrum as PCN
plus increased activity against gram-negative bacilli Treats infections caused by Haemophilus influenzae, Escherichia coli,
and Salmonella and Shigella organismsIneffective against Staphylococcus aureus
Adverse EffectsDiarrhea
ANTIPSEUDOMONIAL PENICILLINSExtended-Spectrum Penicillins
Prototypes: Ticarcillin, Piperacillin
Antipseudomonal Penicillins with Beta-Lactamase Inhibitors
Ticarcillin with clavulanic acid (Timentin)Piperacillin with tazobactam (Zosyn)
ANTIPSEUDOMONIAL PENICILLINSExtended-Spectrum Penicillins
Prototypes: Ticarcillin, Piperacillin Mechanism of Action
Disruption of the bacterial cell wall
UsesAntimicrobial spectra same as for aminopenicillinsplus Pseudomonas aeruginosa, Bacteroides fragilis,
and Enterobacter, Proteus, and Klebsiella spp.Used with aminoglycosides (not in the same IV)
Can be destroyed by bacterial penicillinases
Adverse EffectsSodium overload
Interference with platelet function, leading to increased bleeding time
Ch83
Drugs
ThatWeaken
theBacterialCellW
allICh
83D
rugsThatW
eakenthe
BacterialCellWallI
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
FIRST-GENERATION CEPHALOSPORINSBeta-Lactam Antibiotics
Prototype: Cephalexin (Keflex)
Other First-Generation CephalosporinsCefadroxil (Duricef)
Cefazolin (IV)
FIRST-GENERATION CEPHALOSPORINSBeta-Lactam Antibiotics
Prototype: Cephalexin (Keflex)Mechanism of Action
Weakens the bacterial cell wall
UsesGram-positive infections
Surgical prophylaxis
Adverse EffectsAllergic reaction
Pain at injection siteThrombophlebitis
Rare antibiotic-associated pseudomembranous colitis (AAPMC)
SECOND-GENERATION CEPHALOSPORINSBeta-Lactam Antibiotics
Prototype: Cefprozil (Cefzil)
Other Second-Generation CephalosporinsCefaclor (Ceclor)
Cefotetan (Cefotan)Cefoxitin (Mefoxin)Cefuroxime (Ceftin)
Zinacef
SECOND-GENERATION CEPHALOSPORINSBeta-Lactam Antibiotics
Prototype: Cefprozil (Cefzil)Mechanism of Action
Disruption of the bacterial cell wall
UsesEnhanced activity against gram-negative bacteria
Upper respiratory tract infectionsAcute otitis media (AOM) and sinusitis
Adverse EffectsAllergic reaction
Bleeding tendencies (cefotetan)Thrombophlebitis
Rare antibiotic-associated pseudomembranous colitis (AAPMC)
Ch84
Drugs
ThatWeaken
theBacterialCellW
allIICh
84D
rugsThatW
eakenthe
BacterialCellWallII
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
THIRD-GENERATION CEPHALOSPORINSBeta-Lactam Antibiotics
Prototype: Ceftriaxone (Rocephin)
Other Third-Generation AntibioticsOral
Cefdinir (Omnicef)Cefditoren (Spectracef)
Cefixime (Suprax)Cefpodoxime (Vantin)
Ceftibuten (Cedax)
IM, IVCefoperazone (Cefobid) Cefotaxime (Claforan)
Ceftazidime (Fortaz) [for Pseudomonas aeruginosa]Ceftizoxime (Cefizox)
Fourth-Generation CephalosporinCefepime (Maxipime)
THIRD-GENERATION CEPHALOSPORINSBeta-Lactam Antibiotics
Prototype: Ceftriaxone (Rocephin)Mechanism of Action
Disruption of the bacterial cell wall
UsesActive against gram-negative organisms
Able to penetrate cerebrospinal fluid (CSF)Treats meningitis caused by gram-negative and gram-positive bacteria
Effective for Neisseria gonorrhoeae infection
Adverse EffectsAllergic reactionThrombophlebitis
Rare antibiotic-associated pseudomembranous colitis (AAPMC)Fatal precipitate forms with calcium(Do not mix with Ringer’s lactate)
CARBAPENEMSBroad-Spectrum Beta-Lactam Antibiotics
Prototype: Imipenem (Primaxin)
Other CarbapenemsMeropenem (Merrem IV)
Ertapenem (Invanz)Doripenem (Doribax)
CARBAPENEMSBroad-Spectrum Beta-Lactam Antibiotics
Prototype: Imipenem (Primaxin)Mechanism of Action
Disruption of the bacterial cell wall
UsesActive against gram-positive cocci,
gram-negative cocci, gram-negative bacilli, and anaerobic bacteria
Adverse EffectsGI effects
Hypersensitivity reactionsSuprainfectionsSeizures (rare)
Ch84
Drugs
ThatWeaken
theBacterialCellW
allIICh
84D
rugsThatW
eakenthe
BacterialCellWallII
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
VANCOMYCIN (VANCOCIN)Antibiotic
VANCOMYCIN (VANCOCIN)Antibiotic
Mechanism of ActionInhibits bacterial cell wall synthesis
UsesActive against gram-positive bacteria
Effective for serious infections, such as methicillin-resistant Staphylococcus aureus(MRSA)
Second choice to treat antibiotic-associated pseudomembranous colitis Oral form used in patients who do not respond to metronidazole to delay resistance
Used for patients allergic to penicillin
Adverse EffectsOtotoxicity
Rapid infusion can lead to red man syndrome (ie, flushing,tachycardia, and hypotension)
ThrombophlebitisImmune-mediated thrombocytopenia
NOTE: Infuse over 60 minutes or longer
TETRACYCLINESBroad-Spectrum Antibiotics
Prototype: Doxycycline (Vibramycin)
Other TetracyclinesTetracycline (Sumycin)Minocycline (Minocin)
Demeclocycline (Declomycin)
TETRACYCLINESBroad-Spectrum Antibiotics
Prototype: Doxycycline (Vibramycin)Mechanism of Action
Suppresses bacterial growth by inhibiting protein synthesisBinds to 30S ribosomal subunit to prevent the addition of amino acids
BacteriostaticUses
Rocky Mountain spotted fever, typhus fever, Q feverInfections caused by Chlamydia trachomatis
Brucellosis, choleraPneumonia caused by Mycoplasma pneumoniae
Lyme disease, anthraxGastric infections with Helicobacter pylori (peptic ulcer disease [PUD])
Periodontal disease and acneCommunity-acquired methicillin-resistant S. aureus (CA-MRSA)
Adverse EffectsGI irritation, suprainfection (AAPMC)
Overgrowth with fungi (Candida albicans)Discoloration of teeth (avoid in children ,8 years old)
Do not give to pregnant womenHepatotoxicity, exacerbation of renal impairment
Photosensitivity, vestibular toxicityChelating agents interfere with absorption
Do not administer with:milk products, calcium, iron, magnesium, and laxatives
Ch84
Drugs
ThatWeaken
theBacterialCellW
allIICh
84D
rugsThatW
eakenthe
BacterialCellWallII
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
MACROLIDESBroad-Spectrum Antibiotic
Prototype: Erythromycin
Other MacrolidesClarithromycin (Biaxin)
Azithromycin (Zithromax)Dirithromycin (Dynabac)
Troleandomycin (Tao)
MACROLIDESBroad-Spectrum Antibiotic
Prototype: ErythromycinMechanism of Action
Inhibits bacterial cell wall synthesisBinds to the 50S ribosomal subunit to block addition of amino acids
UsesActive against most gram-positive and some gram-negative organisms
Treats atypicals such as:Pneumonia caused by Legionella pneumophila and Mycoplasma pneumoniae
Bordetella pertussis, Corynebacterium diphtheriaCan be used as an alternative to PCN in allergic individuals
Treats chlamydial infections (urethritis, cervicitis)
Adverse EffectsGI effects, liver injury
Inhibitor of cytochrome P450Increases levels of theophylline, carbamazepine, and some statins
QT prolongation and sudden cardiac death
CLINDAMYCIN (CLEOCIN)Antibiotic
CLINDAMYCIN (CLEOCIN)Antibiotic
Mechanism of ActionInhibits bacterial protein synthesis
UsesUsed as an alternative to penicillin for serious gram-positive anaerobic
infectionsBacteroides fragilis, Fusobacterium sp., Clostridium perfringens
Adverse EffectsAntibiotic-associated pseudomembranous colitis (AAPMC)
Diarrhea
Ch85
BacteriostaticInhibitors
ofProteinSynthesis
Ch85
BacteriostaticInhibitors
ofProteinSynthesis
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
LINEZOLID (ZYVOX)Oxazolidinones Antibiotic
LINEZOLID (ZYVOX)Oxazolidinones Antibiotic
Mechanism of ActionBacteriostatic inhibitor of protein synthesis
Binds to the 23S portion of the 50S ribosomal subunit
UsesActive against aerobic and gram-positive bacteria
Enterococcus faecium (vancomycin sensitive and vancomycin resistant)Staphylococcus aureus (methicillin-sensitive and methicillin-resistant strains)
Staphylococcus epidermidis (methicillin-resistant strains)Streptococcus pneumoniae (PCN sensitive and PCN resistant)
Adverse EffectsGI effects
Myelosuppression (reversible)Neuropathy
HTN (blocks MAO)
AMINOGLYCOSIDESNarrow-Spectrum Antibiotics
Prototype: Gentamicin
Other AminoglycosidesTobramycin
Amikacin (Amikin)
AMINOGLYCOSIDESNarrow-Spectrum Antibiotics
Prototype: GentamicinMechanism of Action
Disrupts bacterial protein synthesisBinds to the 30S ribosomal subunit
UsesEffective against aerobic gram-negative bacilli
Serratia marcescens, Proteus mirabilis, Pseudomonas aeruginosa
Adverse EffectsNephrotoxicity (renal dosing required to avoid toxic drug levels)
Ototoxicity (requires peak and trough level monitoring)Intensifies neuromuscular blockade, leading to respiratory arrest
Incompatible with PCN
Ch85
BacteriostaticInhibitors
ofProteinSynthesis
Ch86
Am
inoglycosides:BactericidalInhibitorsofProtein
Synthesis
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
SULFONAMIDES AND TRIMETHROPRIMPrototype: Trimethoprim/Sulfamethoxazole
(Bactrim, Septra)
SULFONAMIDES AND TRIMETHROPRIMPrototype: Trimethoprim/Sulfamethoxazole
(Bactrim, Septra)Mechanism of Action
Combination antibiotic that inhibits bacterial synthesis of folic acid
UsesUrinary tract infections
Pneumocystis pneumonia (PCP) caused by Pneumocystis jiroveci
Adverse EffectsGI effects
Hypersensitivity reactions (Stevens-Johnson syndrome)Not for use in patients with sulfa allergies
Hematologic effects: Agranulocytosis,leukopenia, thrombocytopenia, aplastic anemia
Hemolytic anemia in patients with G6PD deficiencyKernicterus (do not use in infants ,2 months or pregnant women near term)
Crystalluria, leading to renal damage (increase fluids)CNS effects, hyperkalemia, photosensitivity
Increases the effects of sulfonylurea, leading to hypoglycemia
FLUOROQUINOLONESPrototype: Ciprofloxacin (Cipro)
Other FluoroquinolonesRespiratory fluoroquinolones:
Moxifloxacin (Avelox)* and Levofloxacin (Levaquin)Gemifloxacin (Factive)*
*Prolongs QT interval
FLUOROQUINOLONESPrototype: Ciprofloxacin (Cipro)
Mechanism of ActionInhibits bacterial DNA and cell division
UsesInfections of the urinary, respiratory, and GI tracts, bones,
joints, skin, and soft tissuesAnthrax
Adverse EffectsAchilles tendon rupture and tendinitis (black box warning)
GI upsetCNS effects (dizziness, headache, and restlessness)
Do not take with milk products or ironElevates levels of warfarin
Not recommended for children under age 18 Avoid in pregnancy
Ch87
Sulfonamides
andTrim
ethoprimCh
90M
iscellaneousA
ntibacterialDrugs
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
METRONIDAZOLE (FLAGYL)Antibacterial Drug
METRONIDAZOLE (FLAGYL)Antibacterial DrugMechanism of Action
Causes cell death by damaging bacterial DNA
UsesProtozoal infections
Infections caused by obligate anaerobic bacteria (Bacteroides fragilis)Infections of the CNS, abdominal organs, bones, joints, skin, and soft tissue
Infections of the genitourinary tract (Trichomonas vaginalis)Drug of choice for antibiotic-associated colitis caused by
Clostridium difficileEradicates Helicobacter pylori
Used as prophylaxis in colorectal or abdominal surgery
Adverse EffectsNausea, headache, dry mouth, metallic taste
Vertigo, numbness in the extremitiesDark discoloration of urine
Disulfiram-like effect (vomiting) when used with alcoholIncreases warfarin levels
ANTIFUNGAL AGENTSPrototype: Itraconazole (Sporanox)
Other Azole AntifungalsFluconazole (Diflucan)Voriconazole (Vfend)
Ketoconazole (Nizoral)Posaconazole (Noxafil)Miconazole (Monistat)
Clotrimazole
Other Antifungal DrugsAmphotericin B (causes nephrotoxicity)
Caspofungin (Cancidas)Micafungin (Mycamine)Anidulafungin (Eraxis)Flucytosine (Ancibon)Nystatin (Mycostatin)Terbinafine (Lamisil)Butenafine (Lotrimin)
Ciclopirox (Loprox, Penlac Nail Lacquer)
ANTIFUNGAL AGENTSPrototype: Itraconazole (Sporanox)
Mechanism of ActionCauses bacterial cell wall to leak
UsesSystemic and superficial mycoses (fungi)
Adverse EffectsGI effects, headache, abdominal pain, and edema
Cardiac suppressionLiver injury
Inhibits hepatic drug-metabolizing enzymesDrug reactions with digoxin, warfarin, sulfonylureas, statins,
proton pump inhibitors (PPIs)
Ch90
Miscellaneous
AntibacterialD
rugsCh
91A
ntifungalAgents
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
ANTIFUNGAL AGENTGriseofulvin
ANTIFUNGAL AGENTGriseofulvin
Mechanism of ActionInhibits fungal mitosis
UsesSuperficial mycoses (fungi)
Dermatophytic infections of the skin, hair, and nailsNot active against Candida species or systemic mycoses
May take 3 to 8 weeks to have an effect
Adverse EffectsMay diminish effects of warfarin
ANTIVIRAL DRUGSPrototype: Acyclovir (Zovirax)
Other, Similar AgentsValacyclovir (Valtrex)Famciclovir (Famvir)
Topical AgentsPenciclovir (Denavir)Docosanol (Abbreva)
Ocular AgentsTrifluridine (Viroptic)
Vidarabine ointment (Vira-A)
ANTIVIRAL DRUGSPrototype: Acyclovir (Zovirax)
Mechanism of ActionSuppresses synthesis of viral DNA
UsesHerpes simplex genitalis
Mucocutaneous herpes simplex infectionsVaricella-zoster infections
Adverse EffectsIV administration can lead to phlebitis and nephrotoxicity
Infuse slowly over 1 hour and maintain hydrationOral therapy may lead to nausea, vomiting, diarrhea
Headache and vertigo
Ch91
AntifungalA
gentsCh
92A
ntiviralAgents
I
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
DRUGS FOR HEPATITISPrototype: Interferon Alpha
DRUGS FOR HEPATITISPrototype: Interferon Alpha
Mechanism of ActionDecreases viral replication
UsesHepatitis B and hepatitis C
Adverse EffectsFlulike syndrome
Neuropsychiatric effects—depression and suicidal ideationFatigue, thyroid dysfunction, heart damage
Bone marrow suppression
DRUGS FOR HEPATITISPrototype: Ribavirin (Rebetol, Copegus)
DRUGS FOR HEPATITISPrototype: Ribavirin (Rebetol, Copegus)
Mechanism of ActionUnclear
UsesUsed with interferon for treatment of hepatitis C
Adverse EffectsHemolytic anemia
Fetal harm (FDA Pregnancy Risk Category X)Use a second reliable form of birth control during treatment
and for 6 months after treatment
Ch92
AntiviralA
gentsI
Ch92
AntiviralA
gentsI
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
NUCLEOSIDE/NUCLEOTIDE REVERSE TRANSCRIPTASEINHIBITORS (NRTIs) Antiretroviral Drugs
Prototype: Zidovudine (Retrovir)
Other NRTIs and CombinationsDidanosine (Videx)
Stavudine (Zerit)Lamivudine (Epivir)Abacavir (Ziagen)
Tenofovir disoproxil fumarate (Viread)Emtricitabine (Emtriva)
Zalcitabine (Hivid)Abacavir/zidovudine/lamivudine (Trizivir)
Abacavir/lamivudine (Epzicom)Emtricitabine/tenovir (Truvada)
Lamivudine/zidovudine (Combivir)Emtricitabine/tenofovir/efavirenz (Atripla)
NUCLEOSIDE/NUCLEOTIDE REVERSE TRANSCRIPTASEINHIBITORS (NRTIs)Antiretroviral Drugs
Prototype: Zidovudine (Retrovir)Mechanism of Action
Suppress the synthesis of viral DNA by blocking transcriptasePenetrates the CNS better than most antiretrovirals
UsesHIV infection
Adverse EffectsAnemia and neutropenia from bone marrow suppressionLactic acidosis with hepatomegaly and hepatic steatosis
Gastrointestinal effectsCNS reactions (headache, insomnia, confusion, anxiety, and seizures)
Myopathy
NON-NUCLEOSIDE REVERSE TRANSCRIPTASEINHIBITORS (NNRTIs)Antiretroviral Drugs
Prototype: Efavirenz (Sustiva)
Other NNRTIsNevirapine (Viramune)
Delavirdine (Rescriptor)Etravirine (Intelence)
NON-NUCLEOSIDE REVERSE TRANSCRIPTASEINHIBITORS (NNRTIs)Antiretroviral Drugs
Prototype: Efavirenz (Sustiva)Mechanism of Action
Binds directly to HIV reverse transcriptaseInhibits reverse transcriptase
UsesHIV infection
Adverse EffectsCNS symptoms
Rash, Stevens-Johnson syndromeFetal harm
Liver damageMany drug-drug reactions
Ch93
AntiviralA
gentsII
Ch93
AntiviralA
gentsII
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
PROTEASE INHIBITORSAntiretroviral Drugs
Prototype: Ritonavir (Norvir)
Other Protease InhibitorsLopinavir/ritonavir (Kaletra)
Indinavir (Crixivan)Saquinavir (Invirase)Nelfinavir (Viracept)
Amprenavir (Agnerease)Fosamprenavir (Lexiva)
Atazanavir (Reyataz)Tipranavir (Aptivus)
Darunavir/ritonavir (Prezista)
PROTEASE INHIBITORSAntiretroviral Drugs
Prototype: Ritonavir (Norvir)Mechanism of Action
Inhibits the enzyme protease, which HIV requires to mature
UsesHIV infection
Adverse EffectsHyperglycemia/diabetes, fat maldistribution, hyperlipidemia
Increased bleeding in hemophiliac patientsReduced bone mineral density
Elevation of serum transaminasesCan increase or decrease levels of other drugs
Many drug-drug interactions
INTEGRASE INHIBITORSAntiretroviral Drugs
Prototype: Raltegravir (Isentress)
Other Drugs for HIV
HIV Fusion InhibitorEnfuvirtide (Fuzeon)
Chemokine Receptor CCR5 AntagonistMaraviroc (Selzentry)
INTEGRASE INHIBITORSAntiretroviral Drugs
Prototype: Raltegravir (Isentress)Mechanism of Action
Inhibits integrase to stop HIV replication
UsesHIV infection
Adverse EffectsDiarrhea, nausea, fatigue, headache, and itching
Possible myopathy and rhabdomyolysis
Ch93
AntiviralA
gentsII
Ch93
AntiviralA
gentsII
Foldhere
Foldhere
Cut here Cut here
Copyright © 2010 by Saunders, an imprint of Elsevier Inc.
Dietary Supplement
Black cohosh
Coenzyme Q-10
Cranberry juice
EchinaceaFeverfew
Flaxseed
Garlic
Ginger root
Uses
Menopausal symptoms
May reduce myalgias associated with statins
Prevents bacteria from adhering to urinary tract
Stimulates immune systemMigraine prophylaxis
Dyslipidemia and constipation
Dyslipidemia and hypertension
Vertigo, nausea, and vomitingAnti-inflammatory effects
Potential Problems
Liver toxicityComes mixed with St. John’s
wort; many drug-drug reactionsMay antagonize the effects of
warfarinGI upset and formation of uric
acid kidney stonesAllergic reactionsSuppresses platelet
aggregation-risk of bleedingSuppresses platelet
aggregation-risk of bleedingSuppresses platelet
aggregation-risk of bleedingSuppresses platelet
aggregation-risk of bleedingHigh doses can cause
spontaneous abortion
Commonly Used Dietary Supplements Ch107
Dietary
Supplements
Dietary Supplement
Ginkgo bilobaGlucosamineGreen tea
KavaMa huangProbiotics
Saw palmetto
Soy
St. John’s wort
Valerian root
Uses
Improves age-related memoryOsteoarthritisImproves mental clarity,
weight loss, cancer preventionAnxietyStimulantIrritable bowel syndrome,
antibiotic-associated diarrheaBenign prostatic hypertrophy
Prevention of cancerMenopausal symptomsMild to moderate depression
Sedative, promotes sleep
Potential Problems
May suppress coagulationIncreased risk of bleedingIncreased heart rate, hepatotoxicityReduces effects of warfarinHepatotoxicity, sedationStroke, MI, and deathFlatulence
Suppresses platelet aggregation-risk of bleeding
Fetal harm in womenIncreased risk of oxalateKidney stonesPhotosensitivityAccelerates metabolism of
many drugsSerotonin syndromeDrowsiness
Commonly Used Dietary Supplements